rfhg_138129.1

Basic information about the TSS

---

TSS ID: rfhg_138129.1 Species: human Chr: chr11		Start: 62856181 End: 62856239 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2456936,EH38E1542971)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000535296.5:-13 GeneID: 6520 HGNC/MGI_ID: HGNC:11026 UniProt_ID: F5GZS6 Nearer transcript ids and distances: ENST00000681215.1:-20 ENST00000377889.6:-37 BC003000:-37 ENST00000377891.6:-70 ENST00000680725.1:-70 AK025584:-70 ENST00000538084.2:-72 ENST00000681569.1:-72 NM_001012664.3:-72 NM_001012662.3:-72 NM_002394.6:-72 ENST00000377890.6:-79 ENST00000681467.1:-79 BC001061:-79 ENST00000680729.1:-177 ENST00000680002.1:-177 view more...

Gene_name: solute carrier family 3 member 2 Gene_symbol: SLC3A2 Gene_synonyms: 4F2 4F2HC 4T2HC CD98 CD98HC NACAE Gene_source: HGNC:11026

TATA-Box annotation

---

Distance to TSS:	101
Nearest PromoterID:	NM_001012664
Entrez ID:	6520
Nearest Unigene:	Hs.502769
Nearest Refseq:	NM_002394
Nearest Ensembl:	ENSG00000168003
Gene Name:	solute carrier family 3 member 2
Gene Alias:	4F2|4F2HC|4T2HC|CD98|CD98HC|MDU1|NACAE
Gene Type:	protein-coding
CpG%:	0.034483
GC%:	0.610169
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SLC3A2 p2@SLC3A2 p3@SLC3A2 p4@SLC3A2 p5@SLC3A2 p6@SLC3A2 p7@SLC3A2 p8@SLC3A2 p9@SLC3A2 p10@SLC3A2
Sample		p1@SLC3A2	p2@SLC3A2	p3@SLC3A2	p4@SLC3A2	p5@SLC3A2	p6@SLC3A2	p7@SLC3A2	p8@SLC3A2	p9@SLC3A2	p10@SLC3A2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	140.26	32.34	33.70	6.82	17.92	2.73	2.73	0.58	0.97	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	129.08	34.60	34.19	5.06	20.23	2.02	3.24	0.40	1.42	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	125.97	36.27	31.06	4.82	23.34	2.51	4.05	0.58	0.58	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	118.51	27.86	29.73	5.61	22.25	4.16	2.08	0.83	1.46	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	133.85	38.02	37.34	5.40	23.62	2.47	2.02	0.90	1.35	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	118.61	31.78	31.59	6.20	18.61	1.74	2.33	0.97	0.78	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	101.32	45.10	41.18	5.45	30.72	5.23	9.15	1.96	1.31	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	100.76	37.79	37.30	6.30	27.37	3.63	6.06	1.21	0.48	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	92.54	42.10	38.47	5.56	31.84	3.63	4.27	0.64	0.85	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	224.89	196.49	60.86	13.33	48.11	56.22	100.85	11.01	0.58	3.48
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	238.90	190.39	61.44	14.96	50.13	51.34	93.38	12.53	4.04	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	200.84	160.59	53.26	11.79	39.03	55.70	75.62	14.23	2.44	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	24.50	12.57	2.90	2.58	0.97	1.13	0.32	0.81	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.51	10.98	5.26	2.41	1.20	0.75	0.75	0.45	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	23.93	10.98	4.39	1.54	0.88	0.44	0.22	1.10	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	26.16	10.81	3.52	2.26	0.50	1.26	0.50	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	23.81	8.30	2.62	1.75	0.44	0.44	0.44	0.66	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	31.64	5.06	3.80	1.27	0.84	0.00	0.00	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.59	17.06	2.13	2.67	0.00	0.00	0.53	0.53	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	29.49	10.23	5.12	2.41	1.20	0.60	0.00	0.90	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	32.74	11.36	2.81	2.41	1.20	1.07	0.00	1.34	0.53	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	38.32	12.95	3.97	1.73	1.04	0.52	0.17	1.21	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	38.65	9.18	3.75	2.33	0.52	0.52	0.52	1.29	0.26	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	42.22	12.38	4.13	2.91	1.21	0.97	0.24	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	35.86	10.84	3.87	3.10	1.03	0.26	0.77	1.29	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	38.93	14.56	2.22	1.90	0.63	0.63	0.32	0.95	0.32	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.67	9.89	2.20	4.95	0.55	1.10	1.10	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	42.20	13.20	2.59	2.36	1.18	0.47	0.71	1.18	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	27.62	10.34	2.75	2.91	0.65	0.97	0.65	0.32	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	29.68	10.68	1.81	0.72	0.36	1.63	0.18	1.27	0.54	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	25.33	10.26	1.67	1.05	1.47	0.84	0.42	0.63	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	24.03	10.55	2.15	1.17	0.59	0.59	0.39	0.78	0.20	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	26.17	11.61	3.38	0.84	0.42	0.00	0.21	0.63	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	34.64	10.39	2.47	1.48	0.82	0.16	0.49	0.66	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.75	8.41	2.62	1.31	0.00	0.93	0.56	0.56	0.00	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	31.43	12.26	1.92	2.11	0.57	0.38	0.00	1.15	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	31.27	7.36	2.04	3.27	0.20	0.41	0.20	0.82	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	28.41	9.07	1.21	2.22	0.60	0.20	0.00	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	35.65	4.05	2.70	1.89	0.81	0.00	0.00	1.89	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	33.61	8.88	2.16	2.40	0.72	0.24	0.24	0.24	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	34.11	9.18	1.18	2.12	0.71	0.71	0.24	1.18	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	45.09	8.49	3.95	2.05	1.46	0.15	0.88	0.88	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	35.85	7.80	3.59	1.69	1.69	0.00	0.63	0.63	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	35.84	9.97	2.97	2.10	0.52	0.00	0.35	0.17	0.17	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	39.55	9.44	3.21	3.21	0.80	1.20	0.00	0.60	0.00	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	47.46	6.05	1.86	2.56	0.93	0.23	0.70	0.70	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	40.78	8.16	3.84	3.12	1.20	0.24	0.48	1.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	45.30	6.86	5.07	2.98	0.89	0.30	0.60	0.89	0.89	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	52.66	6.70	4.55	4.07	1.44	0.24	0.24	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	38.62	5.66	3.64	2.83	0.81	0.00	0.40	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	52.88	6.76	2.87	3.48	2.05	0.20	0.61	0.41	0.41	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	60.93	7.34	4.23	2.67	2.22	0.00	0.44	0.00	0.00	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	57.84	4.61	6.03	2.13	1.77	0.00	0.71	0.00	0.35	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	60.97	5.63	4.31	5.30	3.65	0.66	0.33	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	80.54	10.91	3.36	3.36	5.87	0.00	0.84	0.84	0.00	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	79.91	9.64	4.59	6.43	2.30	0.92	0.92	0.46	0.92	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	52.83	8.75	5.51	3.57	0.65	0.32	0.65	0.00	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	56.85	5.46	4.82	2.89	3.21	0.64	0.32	0.00	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	87.07	6.60	5.03	7.86	2.51	0.63	0.63	0.31	0.31	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	39.48	5.64	6.35	2.82	1.41	0.71	0.00	0.00	0.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	46.55	5.61	3.93	1.68	2.24	1.68	0.00	0.00	0.56	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	70.86	19.11	4.78	3.98	0.00	0.80	0.80	0.00	0.00	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	58.44	9.85	3.06	2.38	3.06	0.00	0.34	1.02	0.00	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	35.74	11.70	3.25	0.97	1.62	1.62	0.00	0.00	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	42.60	13.49	2.13	0.00	2.84	0.35	0.35	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	16.16	0.00	16.16	0.00	0.00	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	189.54	7.90	0.00	7.90	0.00	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	44.85	4.88	4.88	2.44	2.93	2.44	0.49	0.00	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	47.11	7.44	3.47	2.48	0.99	0.00	0.00	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	47.38	5.63	3.28	2.35	1.41	0.47	0.00	0.94	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.45	14.90	2.32	1.66	2.32	1.66	0.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	24.75	9.28	2.78	1.55	1.86	0.00	0.00	0.00	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.96	9.78	2.45	1.22	1.83	1.22	0.92	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	139.85	14.89	0.79	6.65	0.00	2.06	0.79	0.79	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	77.33	13.32	0.64	3.69	0.16	2.09	0.64	0.48	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	132.32	14.50	1.27	7.00	0.13	1.15	1.91	1.78	0.00	0.25
Adipocyte - omental, donor2	11474-119C7	53.82	7.47	1.49	3.74	0.75	1.49	0.75	2.24	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	72.01	11.72	0.33	4.35	0.33	3.68	0.33	1.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	67.63	7.66	4.47	5.10	0.64	1.91	0.64	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	105.55	3.30	3.30	1.10	0.00	7.70	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	197.81	0.90	3.16	10.39	0.90	1.81	0.45	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	49.70	3.30	0.87	2.95	0.17	0.52	0.35	1.22	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	76.66	13.10	1.17	3.13	0.39	2.93	0.78	1.17	0.00	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	80.30	9.52	2.06	3.09	1.29	1.03	0.51	0.00	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	102.87	15.89	0.56	4.18	0.84	1.39	0.28	0.56	0.00	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	107.57	18.22	0.59	2.35	0.59	2.94	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	41.50	6.03	0.88	1.37	0.00	0.32	0.32	0.08	0.08	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	69.07	10.01	2.58	2.58	0.32	1.61	0.32	0.97	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	92.77	6.93	0.53	2.67	0.00	0.53	0.53	0.53	0.00	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	58.98	13.91	0.00	2.23	0.00	0.00	0.00	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	42.42	9.15	0.83	2.50	0.00	0.83	0.00	0.00	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	59.53	4.02	1.26	3.77	0.50	0.50	1.00	0.75	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	50.72	4.25	0.65	3.27	0.00	1.96	0.00	0.65	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	33.80	4.87	0.30	0.61	0.00	0.61	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	128.40	7.96	26.52	6.85	10.17	0.88	0.66	0.22	0.88	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	128.37	12.19	29.40	8.96	19.72	2.51	0.72	1.79	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	137.77	14.38	9.58	5.99	3.59	2.40	0.00	1.20	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	168.57	2.70	8.46	8.82	6.48	1.08	0.72	0.18	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	102.08	1.67	3.35	6.69	3.35	1.67	3.35	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	79.92	4.52	3.90	4.31	3.29	0.21	0.41	0.82	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	50.81	2.29	1.95	4.81	1.03	1.37	0.34	0.69	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	31.35	2.69	1.71	3.18	0.73	0.73	0.00	0.49	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	33.25	3.15	0.90	1.80	1.35	0.00	0.45	0.90	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	37.77	9.12	1.30	1.74	0.87	0.43	0.00	0.00	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	12.84	2.14	2.14	2.14	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	33.48	7.47	0.90	2.69	0.30	0.60	0.60	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	37.94	3.79	2.53	3.79	1.26	0.00	0.00	0.00	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	34.98	2.64	1.32	2.64	1.98	1.32	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	38.01	6.50	1.62	3.25	0.97	0.00	0.65	1.30	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	42.23	1.46	2.91	2.43	0.97	0.49	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	35.04	6.53	0.00	2.97	0.59	0.00	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	40.68	4.52	1.51	2.64	0.75	0.75	0.38	0.75	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	32.66	5.81	0.73	1.45	0.00	0.00	0.73	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	40.12	8.78	2.51	5.02	2.51	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	44.81	4.61	1.32	4.28	1.32	0.82	0.49	0.99	0.33	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	39.58	1.36	1.36	1.36	2.73	0.00	1.36	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	32.12	3.62	0.90	2.71	1.06	0.75	0.45	0.15	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	41.26	2.68	0.54	1.61	1.07	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	38.35	4.53	1.32	3.02	1.32	0.94	0.38	0.00	0.19	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	40.09	4.54	0.53	3.21	0.00	0.53	0.53	0.53	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	28.29	7.80	1.95	0.98	2.93	0.98	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	34.17	4.15	0.83	2.49	0.50	0.33	0.00	0.83	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	40.82	6.00	3.60	1.20	0.00	0.00	1.20	0.00	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	7.08	3.54	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	37.57	2.57	1.03	0.86	0.51	1.03	0.17	0.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	50.34	4.19	4.19	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	40.29	6.31	0.97	2.91	1.94	0.49	0.00	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	37.95	2.28	0.76	2.66	0.00	2.28	0.00	0.38	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	41.19	2.42	1.21	2.42	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	38.76	1.71	0.57	2.85	0.57	1.14	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	42.54	3.21	2.14	2.99	0.43	0.86	0.43	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	37.94	3.61	1.55	1.81	1.03	0.52	1.03	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	34.72	5.63	1.41	1.41	0.00	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	24.44	5.14	0.96	2.57	0.32	0.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	34.25	4.99	0.00	2.85	0.00	1.43	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.17	4.68	0.58	1.75	0.58	0.00	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.41	4.52	1.20	1.81	0.90	0.30	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	39.20	5.94	1.19	1.19	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	31.02	5.59	0.00	1.53	1.53	1.53	0.51	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	34.64	4.58	0.76	1.27	0.51	0.25	0.25	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	3.81	0.00	1.91	0.64	0.00	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	27.62	6.90	1.73	2.59	0.86	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	28.37	3.18	1.27	2.12	0.42	0.85	0.21	0.64	0.00	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	23.20	4.93	1.16	2.90	0.58	0.29	0.29	0.29	0.00	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	37.79	4.72	3.78	3.78	0.94	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.43	4.92	1.19	0.51	0.68	1.19	0.00	0.34	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	4.63	2.32	6.95	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	35.91	4.23	0.00	2.11	6.34	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	33.45	5.79	1.29	1.72	1.07	0.43	0.43	0.43	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	34.29	5.41	0.00	1.80	0.60	0.00	0.00	1.80	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	39.36	6.56	2.92	2.92	0.00	0.00	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	39.31	4.37	0.69	2.30	1.15	0.46	0.00	0.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	2.55	0.00	7.65	0.00	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	36.86	6.10	2.54	3.81	1.02	0.76	0.25	0.25	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	39.43	8.26	1.65	2.27	0.21	1.03	0.62	0.83	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	38.56	6.73	0.92	3.37	0.92	0.31	0.00	0.00	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	38.24	6.21	0.96	1.91	1.43	0.96	0.00	0.48	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	31.93	2.88	0.89	1.33	1.33	0.44	0.22	0.22	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	47.30	1.53	3.05	0.00	3.05	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	37.66	3.88	0.55	2.22	1.66	0.55	0.00	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	41.31	3.18	1.59	1.06	1.06	0.26	0.53	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	35.98	4.72	0.73	3.27	1.45	0.36	0.00	0.36	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	53.18	13.26	12.90	5.04	4.54	0.74	0.25	0.37	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	38.68	7.19	10.78	4.11	2.91	1.03	0.51	0.34	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	130.04	23.28	6.50	6.29	3.78	1.26	0.42	2.73	0.21	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	45.32	23.70	9.41	1.05	1.05	0.35	0.35	0.70	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	41.41	22.49	9.22	2.10	3.72	0.32	0.65	0.49	0.65	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	38.78	11.93	10.74	1.49	1.94	0.60	0.00	0.30	0.60	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	37.39	16.17	19.38	3.21	9.06	0.57	0.46	0.46	0.46	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	31.70	14.16	25.31	2.88	12.90	1.00	0.25	0.38	0.50	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	33.00	14.45	25.83	3.41	8.88	0.23	0.46	0.34	0.68	0.11
Basophils, donor1	12241-129G9	157.70	9.42	0.00	4.97	0.26	8.63	1.31	0.78	0.00	2.88
Basophils, donor2	12242-129H1	158.75	12.99	0.36	3.61	1.44	8.66	0.36	0.36	0.00	1.80
Basophils, donor3	12243-129H2	124.80	9.55	0.88	3.82	0.29	9.55	1.47	0.88	0.00	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	319.09	12.07	33.42	15.95	11.43	1.29	0.65	1.51	0.65	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	139.44	12.34	25.60	13.72	11.43	0.91	1.37	0.00	0.00	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	121.95	14.35	7.17	21.52	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	155.03	6.28	55.86	8.16	29.50	1.26	1.26	0.00	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	149.93	7.90	43.05	12.06	19.96	1.66	1.25	1.25	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	363.86	25.56	29.94	21.42	11.51	11.74	5.99	3.68	1.61	2.07
Bronchial Epithelial Cell, donor7	11769-123I5	183.90	9.18	19.25	11.34	3.78	0.54	0.18	1.80	1.26	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	41.63	6.08	54.93	3.50	3.19	0.72	0.31	0.62	1.44	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	64.75	18.87	57.99	6.29	9.08	0.47	0.70	0.70	2.33	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	99.45	11.83	11.19	8.95	2.88	2.24	0.64	0.32	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	165.47	0.00	10.34	20.68	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	108.77	7.89	0.00	3.94	0.00	3.38	0.56	1.69	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	85.38	7.61	0.19	4.27	0.56	5.20	0.37	0.00	0.19	1.30
CD14+ Monocytes, donor3	11381-118B4	99.23	11.85	0.44	2.41	0.44	3.95	0.66	0.22	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	180.02	10.47	1.42	3.96	0.00	2.83	0.57	0.85	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	116.76	14.40	2.27	2.65	0.00	0.76	0.38	0.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	134.45	7.23	1.64	3.94	0.00	1.64	0.33	0.66	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	172.30	47.56	0.00	4.19	0.00	6.94	1.59	1.59	0.00	4.05
CD14+ monocytes - mock treated, donor2	11873-125C1	274.89	32.89	0.00	4.53	0.00	9.05	2.41	1.21	0.00	2.41
CD14+ monocytes - mock treated, donor3	11883-125D2	213.91	36.24	0.00	3.79	0.00	8.53	2.13	1.42	0.00	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	289.77	60.93	0.00	3.68	0.00	17.07	4.69	1.84	0.00	7.87
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	451.56	51.06	0.00	5.80	0.28	31.47	6.07	2.21	0.00	5.52
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	609.66	72.89	0.00	7.69	0.00	40.66	9.67	2.73	0.00	9.17
CD14+ monocytes - treated with BCG, donor1	11860-125A6	345.59	76.75	0.00	4.50	0.00	33.09	9.40	4.50	0.00	8.03
CD14+ monocytes - treated with BCG, donor2	11870-125B7	440.31	67.66	0.00	3.92	0.00	27.42	6.41	3.56	0.00	10.15
CD14+ monocytes - treated with BCG, donor3	11880-125C8	697.29	99.89	0.22	11.10	0.00	40.70	12.84	4.79	0.00	13.71
CD14+ monocytes - treated with Candida, donor1	11868-125B5	275.80	118.23	0.00	4.68	0.00	34.88	7.26	6.09	0.00	11.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	412.92	111.41	0.00	7.92	0.00	54.91	8.98	6.86	0.00	10.03
CD14+ monocytes - treated with Candida, donor3	11888-125D7	658.96	117.59	0.00	12.20	0.00	58.80	16.64	3.33	0.00	13.31
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	235.17	48.34	0.00	4.31	0.15	10.86	4.91	2.83	0.00	5.95
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	393.51	46.89	0.00	5.59	0.00	16.76	5.19	1.40	0.00	4.99
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	549.65	67.87	0.00	10.20	0.00	16.45	8.12	1.87	0.00	8.33
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	371.32	109.59	0.00	5.72	0.23	37.98	11.67	6.63	0.00	8.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	578.63	87.54	0.00	6.56	0.00	30.99	7.46	4.75	0.00	6.33
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	501.06	76.82	0.00	4.36	0.00	38.41	7.42	3.49	0.00	7.42
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	186.95	39.54	0.00	5.38	0.00	5.38	2.15	0.81	0.00	4.03
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	278.61	48.50	0.00	4.54	0.00	15.88	3.31	2.79	0.17	8.03
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	293.73	50.08	0.00	5.89	0.00	13.89	5.47	2.95	0.00	6.31
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	348.87	109.12	0.18	6.25	0.00	38.03	10.84	7.16	0.00	13.04
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	482.25	119.77	0.35	5.99	0.00	45.44	8.81	5.28	0.00	5.28
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	445.74	127.67	0.00	9.21	0.00	44.31	8.77	7.02	0.00	7.46
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	326.60	79.17	0.35	7.67	0.00	28.25	4.88	6.10	0.00	10.46
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	388.77	72.48	0.00	5.95	0.00	39.40	4.46	1.86	0.00	8.18
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	608.50	104.11	0.00	10.99	0.43	41.17	9.27	3.66	0.00	14.01
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	332.09	110.97	0.41	6.96	0.00	27.03	6.14	5.32	0.00	9.83
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	568.60	120.30	0.00	6.95	0.00	39.17	10.20	5.79	0.00	7.42
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	605.04	148.24	0.23	9.28	0.00	40.83	9.98	5.80	0.00	8.82
CD14+CD16+ Monocytes, donor1	11789-124B7	119.01	2.83	0.65	3.92	0.44	0.87	0.87	0.22	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	136.52	4.39	0.92	3.93	0.00	1.15	0.92	0.23	0.00	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	134.09	4.33	0.43	4.98	0.00	2.17	0.22	0.22	0.00	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	144.82	16.35	0.47	3.89	0.31	2.34	1.09	0.31	0.00	1.71
CD14+CD16- Monocytes, donor2	11799-124C8	133.60	21.31	0.17	4.54	0.00	2.10	1.22	0.00	0.17	1.92
CD14+CD16- Monocytes, donor3	11910-125G2	109.48	16.28	0.22	5.13	0.22	3.57	0.00	0.00	0.00	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	82.17	0.77	0.26	0.51	0.00	0.00	0.00	0.26	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	86.95	1.32	0.22	4.17	0.00	0.22	0.44	0.22	0.00	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	99.38	0.21	0.42	4.00	0.00	0.21	0.21	0.00	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	60.97	2.03	0.00	2.03	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	43.39	2.71	6.78	2.03	1.36	0.00	0.00	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	37.28	4.14	2.07	5.18	0.00	0.00	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	83.69	2.13	12.26	2.13	1.60	0.00	0.00	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	65.40	2.14	2.14	2.68	0.54	0.00	0.00	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	47.73	0.70	3.51	0.70	0.70	0.00	0.00	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	47.06	3.92	7.84	3.14	0.00	0.00	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	67.23	3.95	0.00	2.64	0.00	0.00	0.00	0.00	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	78.08	3.29	2.47	3.29	2.47	2.47	2.47	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	90.68	4.35	2.18	5.08	0.73	0.73	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	74.71	4.04	0.50	0.50	1.01	2.02	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	321.23	166.88	24.65	17.37	1.62	5.25	2.02	2.02	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	368.73	149.81	28.76	21.57	1.60	6.79	3.20	2.80	2.40	1.20
CD34+ Progenitors, donor1	11545-120B6	54.22	8.03	0.00	1.00	2.01	3.01	1.00	1.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	96.07	16.29	0.56	5.62	0.56	5.62	1.69	0.56	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	77.03	9.02	22.55	6.76	3.01	1.50	0.38	0.38	1.50	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	73.06	17.59	23.68	7.67	6.54	1.13	0.23	0.90	1.35	0.23
CD4+ T Cells, donor1	11225-116C1	133.18	11.07	1.43	5.00	2.50	1.43	1.79	0.36	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	173.91	20.21	1.22	9.19	2.45	2.45	0.61	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	128.71	17.99	1.83	5.79	4.27	2.74	1.22	0.30	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	71.98	18.38	12.00	5.87	3.57	0.26	0.51	0.00	0.26	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	71.87	20.89	13.03	5.61	2.47	0.90	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	77.04	16.67	11.79	10.92	1.72	0.57	0.29	0.00	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	168.78	31.76	7.11	7.11	0.95	1.42	0.47	0.00	0.47	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	151.00	41.44	11.24	10.53	2.11	3.51	0.70	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	121.96	23.07	0.00	16.48	0.00	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	47.40	19.65	6.21	4.34	4.62	0.43	0.00	0.00	0.14	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	49.65	27.62	10.51	5.76	4.24	0.85	1.02	0.17	0.51	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	53.52	27.40	6.61	5.16	5.96	0.81	0.32	0.32	0.32	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	145.70	21.07	3.14	8.97	3.59	1.34	1.79	0.00	0.45	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	113.90	25.85	6.29	7.34	3.14	1.75	1.40	0.00	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	115.28	16.72	3.96	10.56	3.52	2.64	0.00	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	69.57	8.43	5.48	5.90	4.22	0.00	0.42	0.42	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	45.50	17.24	3.12	2.70	0.83	0.62	0.21	0.00	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	51.12	15.70	7.02	6.35	2.34	0.67	0.67	0.33	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	95.72	13.60	5.17	7.34	0.54	0.27	0.82	0.00	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	79.32	15.01	5.36	4.29	0.00	1.07	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	112.97	23.31	1.79	7.17	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	54.52	14.09	6.49	5.01	5.93	0.56	0.74	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	35.96	13.65	6.28	3.25	3.90	0.65	0.00	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	56.32	20.59	2.94	5.67	5.67	0.42	0.00	0.21	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	143.59	21.24	4.04	9.61	1.01	1.01	0.00	0.51	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	137.34	28.59	3.03	8.23	2.60	0.43	0.43	0.00	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	124.64	22.66	1.31	7.41	2.61	0.87	0.00	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	105.90	21.28	3.96	9.90	0.49	0.49	0.49	0.00	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	96.93	20.31	1.85	3.69	0.00	0.00	0.00	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	111.67	19.54	1.40	1.40	0.00	0.00	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	88.06	15.51	2.22	5.54	0.28	0.83	0.55	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	73.86	15.95	4.66	6.38	0.00	0.00	0.25	0.25	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	86.24	20.02	1.54	10.78	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	96.33	20.77	2.51	5.73	0.36	0.00	0.00	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	102.49	36.01	1.38	12.46	0.00	0.00	0.00	0.00	0.00	2.77
CD8+ T Cells, donor1	11226-116C2	148.97	14.41	0.33	3.27	1.31	3.27	0.33	0.65	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	133.28	19.15	0.00	3.00	2.25	3.38	0.75	0.00	0.00	0.75
CD8+ T Cells, donor3	11383-118B6	125.49	16.41	0.50	4.54	1.26	2.27	1.26	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	61.48	23.17	14.91	3.67	12.85	1.15	0.69	1.15	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	49.85	19.65	12.94	2.64	9.59	2.16	1.92	0.96	0.48	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	51.16	22.16	10.12	2.74	8.75	0.82	1.92	1.09	0.27	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	58.24	18.01	13.81	4.20	9.01	1.50	1.50	0.90	1.20	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	60.96	18.96	11.28	3.36	7.20	2.16	1.44	0.72	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	54.35	19.33	9.32	3.41	10.00	1.59	0.45	0.68	0.00	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	49.54	18.47	11.73	2.82	10.21	1.09	1.52	0.00	0.65	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	43.69	17.90	14.48	3.42	10.79	1.05	0.53	0.79	0.00	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	48.08	17.59	9.85	2.58	11.96	0.94	0.70	0.23	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	60.38	25.96	14.49	2.11	11.77	2.72	1.21	1.81	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	53.74	30.79	13.65	2.03	15.98	1.45	1.74	2.03	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	68.21	26.64	15.72	1.87	13.59	3.20	2.40	0.00	0.00	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	113.38	54.28	7.00	2.19	6.57	2.63	5.69	1.75	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	122.97	60.12	3.19	2.73	4.55	14.57	4.55	3.19	0.00	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	82.05	47.74	0.75	3.73	8.20	4.48	2.24	1.49	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	79.59	18.01	14.41	3.60	6.84	2.52	1.44	0.72	1.08	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	64.45	18.99	13.52	3.45	8.34	1.73	1.44	0.86	0.86	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	50.67	12.02	11.08	3.54	7.78	1.18	3.06	1.18	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	68.45	21.87	14.58	1.58	10.14	1.90	1.58	0.95	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	69.20	19.99	15.38	1.54	8.61	1.54	1.23	0.92	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	58.67	14.11	12.18	3.53	10.26	0.64	1.28	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	94.47	47.04	11.47	5.74	12.24	4.97	1.91	0.38	0.00	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	85.52	44.14	9.46	4.34	11.82	7.09	1.18	2.36	0.39	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	87.74	62.78	15.88	6.05	15.88	3.03	3.03	2.27	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	273.81	282.64	12.85	11.24	13.65	68.25	13.65	15.26	0.00	7.23
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	238.51	271.38	16.09	7.69	7.69	44.06	16.09	21.68	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	242.42	248.43	10.02	9.02	13.02	63.11	20.04	13.02	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	113.32	9.14	3.66	5.48	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	45.46	3.46	2.47	1.98	0.49	0.99	0.49	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	127.65	3.26	6.31	4.84	1.37	1.58	0.42	1.16	0.74	0.00
Chondrocyte - de diff, donor1	11261-116G1	146.29	12.48	7.97	7.63	2.77	2.77	0.00	2.43	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	209.67	6.04	3.20	7.82	0.71	2.13	0.36	0.71	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	113.32	14.34	2.05	6.26	0.68	1.82	0.23	1.93	0.11	0.11
Chondrocyte - re diff, donor2	11339-117F7	90.42	17.01	3.58	4.48	0.00	0.90	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	122.53	16.98	6.47	4.45	0.81	2.83	0.40	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	67.02	18.94	6.66	4.02	1.84	0.23	0.11	0.57	0.34	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	42.33	10.47	6.84	4.28	3.21	1.07	0.43	0.21	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	60.36	9.82	6.46	3.89	2.92	0.44	0.62	0.18	0.09	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	157.17	12.20	3.30	5.96	0.55	1.28	0.46	0.46	0.18	0.18
Corneal Epithelial Cells, donor1	11526-119I5	463.96	16.47	32.94	26.13	5.71	1.54	1.32	1.32	0.88	0.66
Corneal Epithelial Cells, donor2	11606-120I4	321.94	11.38	58.02	26.16	9.10	0.00	0.00	0.00	3.41	1.14
Corneal Epithelial Cells, donor3	11687-122I4	379.10	16.10	49.08	17.13	10.99	3.07	2.30	1.53	2.81	2.30
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	182.93	19.48	7.92	7.76	1.65	0.50	0.00	0.17	0.17	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	203.12	19.24	5.99	8.52	0.95	0.00	0.63	0.32	0.63	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	134.58	31.06	13.80	6.90	0.00	0.00	3.45	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	175.59	12.53	7.24	7.02	2.81	0.97	0.54	0.00	0.32	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	164.67	1.02	0.68	10.25	1.02	0.68	0.34	0.34	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	200.43	1.31	0.00	7.83	0.00	1.31	0.65	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	152.93	0.48	0.00	15.97	0.48	0.00	0.48	0.00	0.00	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	115.57	3.84	18.68	5.84	4.34	1.00	0.33	0.50	1.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	53.98	3.52	9.98	4.11	1.76	0.59	0.00	0.00	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	68.72	5.09	9.05	4.81	3.39	0.28	0.28	0.28	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	78.64	4.72	7.86	3.54	1.97	0.39	0.00	0.39	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	46.83	7.27	7.56	2.04	2.04	0.58	0.29	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	68.70	6.82	13.88	1.88	4.24	1.18	0.47	0.47	1.18	0.24
Endothelial Cells - Artery, donor3	11413-118E9	63.81	4.03	22.09	3.86	4.21	0.35	0.18	0.35	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	36.79	12.63	3.99	0.66	0.00	0.22	0.22	0.44	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	29.82	10.65	2.13	2.13	0.30	0.00	0.30	0.30	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	25.37	9.87	3.66	1.97	0.56	0.85	0.00	0.28	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	38.03	3.57	3.86	1.49	1.49	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	24.99	4.17	12.50	2.60	2.60	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	22.40	1.99	3.12	0.57	0.85	0.43	0.14	0.14	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	55.22	11.20	13.20	2.00	4.40	2.00	0.00	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	51.89	7.86	4.19	3.67	5.24	0.00	0.00	0.00	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	40.75	19.88	11.55	2.36	2.11	0.75	0.25	0.50	1.24	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	41.28	11.51	4.13	0.43	0.22	0.43	0.00	0.22	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	42.01	11.11	8.79	2.20	2.08	0.49	0.00	0.24	1.10	0.00
Endothelial Cells - Vein, donor1	11267-116G7	71.66	10.24	20.48	1.14	4.55	1.14	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	60.07	9.78	12.57	0.00	6.29	0.00	0.00	0.70	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	46.95	7.69	11.62	4.87	3.77	0.63	0.31	0.31	1.10	0.00
Eosinophils, donor1	12244-129H3	121.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	103.97	11.55	0.00	1.65	0.00	0.00	0.00	0.00	0.00	3.30
Eosinophils, donor3	12246-129H5	89.17	14.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	370.64	10.26	51.06	20.03	23.21	1.22	0.49	1.22	2.20	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	297.46	18.72	18.72	14.56	8.32	8.32	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	195.23	0.00	32.54	16.27	16.27	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	96.47	9.85	1.64	4.52	0.41	1.64	0.82	1.23	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	24.31	3.72	0.66	1.75	0.55	0.77	0.88	0.33	0.00	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.75	14.73	0.54	0.54	0.11	5.63	2.17	3.79	0.33	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	102.36	19.77	8.25	4.85	2.30	1.09	1.33	1.33	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	101.40	80.93	3.96	2.73	2.18	5.60	1.64	0.82	0.27	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	61.91	13.08	1.69	2.95	0.53	0.84	0.42	0.74	0.00	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	319.88	75.89	16.34	21.61	5.27	4.74	3.69	1.58	0.53	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	64.45	17.61	4.65	5.32	1.99	2.66	0.66	2.33	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	100.25	5.44	13.61	4.99	3.18	1.36	0.00	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	187.21	6.82	12.13	3.03	10.61	2.27	0.00	0.00	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	133.59	8.52	4.10	5.20	1.89	1.73	1.10	1.26	0.63	0.63
Fibroblast - Cardiac, donor4	11452-119A3	25.16	5.46	0.61	1.21	0.61	0.30	0.00	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	112.82	12.44	3.43	3.68	1.27	3.17	2.28	1.65	0.13	0.51
Fibroblast - Cardiac, donor6	11460-119B2	39.87	9.25	5.46	2.58	0.91	0.76	0.30	0.45	0.30	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	50.25	14.60	3.75	2.01	0.13	0.40	0.40	0.27	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	62.13	4.31	1.73	3.02	0.00	0.00	0.00	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	80.56	4.39	14.65	5.86	4.39	4.39	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	281.61	43.82	16.14	11.53	3.23	13.84	29.06	2.54	0.69	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	79.21	8.65	3.22	4.07	0.17	0.85	1.02	1.36	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	30.99	8.22	4.93	0.94	1.64	0.47	0.00	0.23	0.23	0.47
Fibroblast - Dermal, donor2	11346-117G5	86.32	3.77	11.32	9.43	3.30	0.94	0.47	0.00	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	47.51	8.82	3.51	3.63	0.73	0.97	0.24	0.73	0.36	0.48
Fibroblast - Dermal, donor4	11450-119A1	87.50	11.64	9.38	7.46	4.63	4.07	3.50	1.36	0.11	0.57
Fibroblast - Dermal, donor5	11454-119A5	60.01	10.99	11.69	4.54	2.97	4.19	2.44	1.05	0.17	0.70
Fibroblast - Dermal, donor6	11458-119A9	40.28	10.07	6.98	3.41	5.85	0.97	0.49	0.65	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	28.32	9.37	1.04	1.46	0.42	0.83	0.21	0.42	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	100.08	19.91	3.93	7.07	0.52	2.10	0.79	1.57	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	38.22	9.09	5.53	3.43	0.40	0.79	0.79	0.40	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	85.86	21.85	2.51	3.67	0.48	5.51	2.42	1.45	0.19	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	105.97	13.51	1.04	5.19	0.00	5.19	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	107.13	10.57	0.70	4.76	0.18	3.17	1.41	1.06	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	34.61	12.00	3.43	2.65	1.09	0.47	0.16	0.31	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	21.23	8.38	1.08	1.89	0.41	0.27	0.00	0.68	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.64	4.94	3.18	1.76	0.71	0.71	0.00	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	20.77	7.60	2.34	1.75	0.44	0.58	0.15	0.15	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	30.27	6.68	2.59	2.59	0.27	0.00	0.00	0.55	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	69.76	9.43	4.39	4.83	2.41	1.21	0.44	0.44	0.11	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	73.37	17.02	0.29	3.23	0.29	4.40	2.05	2.35	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	62.53	2.72	5.44	8.16	1.36	0.00	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	52.23	10.45	2.98	7.46	0.00	0.00	1.49	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	51.91	4.22	6.33	4.01	2.74	0.42	0.21	0.42	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	69.97	14.16	9.16	8.33	1.67	1.67	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	40.56	9.79	2.80	2.80	0.00	4.20	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	107.47	16.51	3.92	7.00	2.52	3.36	2.24	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	69.42	12.18	3.65	5.68	1.22	0.41	0.41	1.62	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	151.78	15.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	56.25	6.98	3.49	2.91	1.36	1.55	0.97	1.16	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	51.42	10.47	7.74	3.79	2.28	1.67	0.61	0.76	0.61	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	21.42	6.43	3.06	1.84	0.61	0.61	0.00	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	84.34	9.92	2.67	4.96	0.00	3.43	0.00	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	111.24	15.66	1.08	5.13	0.81	2.16	0.27	0.81	0.00	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	95.33	8.81	0.93	4.06	0.00	2.67	0.35	1.04	0.00	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	101.14	3.54	13.04	5.20	3.43	0.99	0.33	0.44	0.66	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	80.46	9.35	6.71	7.31	2.24	0.81	0.81	0.00	0.61	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	58.13	6.01	7.35	4.01	4.01	0.00	0.00	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	66.42	5.54	1.98	1.98	1.19	0.40	0.79	0.40	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	210.16	30.56	10.52	14.88	5.75	3.37	1.39	0.40	0.60	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	114.03	17.23	1.60	5.86	0.89	2.49	1.42	0.89	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	94.40	15.57	2.96	5.12	0.79	2.56	0.00	0.99	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	281.60	51.15	14.44	19.56	10.83	4.21	2.41	0.60	0.60	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	86.90	16.19	3.45	3.24	1.30	1.08	0.86	1.51	0.11	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	199.17	70.86	5.31	13.41	1.52	6.83	1.52	0.76	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	110.10	16.57	3.45	7.06	0.98	1.97	0.33	0.98	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	250.83	41.71	9.62	15.44	6.62	3.41	1.00	1.00	0.60	0.00
Fibroblast - skin normal, donor2	11561-120D4	112.52	13.36	2.81	10.75	0.90	2.31	1.00	1.31	0.20	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	186.78	34.15	6.35	10.28	6.35	6.04	1.21	0.60	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	97.01	19.63	1.66	4.14	1.16	1.49	0.58	1.33	0.17	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	67.18	12.65	2.56	4.44	0.34	2.91	0.68	1.71	0.17	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	191.80	31.53	5.25	13.14	2.30	3.28	0.66	0.00	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	86.07	8.84	2.56	5.75	1.49	1.49	0.75	0.43	0.11	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	69.67	6.92	4.89	4.22	1.01	0.51	0.17	0.34	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	106.79	6.12	1.88	6.43	0.63	1.25	0.47	1.73	0.31	1.73
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00	0.00	0.00	0.00	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	99.35	9.59	6.97	6.97	4.36	0.87	0.00	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	252.93	11.61	15.60	13.18	7.28	0.52	0.17	0.00	0.17	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	131.68	7.81	17.96	9.37	11.71	0.52	0.26	0.26	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	176.30	10.99	10.22	9.96	7.15	0.00	0.51	0.26	0.51	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	81.91	6.12	61.24	4.59	20.67	0.00	0.00	0.00	5.36	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	98.90	7.02	104.64	5.74	26.16	0.00	1.28	0.64	7.02	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	113.53	29.95	122.66	8.84	29.67	3.14	1.43	0.00	9.41	4.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	64.80	28.40	37.50	5.24	5.52	1.93	2.21	3.03	4.41	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	95.21	56.40	30.82	6.85	8.45	5.25	8.90	7.08	2.97	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	79.05	24.17	88.37	6.74	18.03	2.38	1.39	0.59	5.75	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	54.98	31.98	42.56	3.70	3.17	2.38	1.06	1.32	4.49	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	118.39	56.42	18.92	4.24	4.24	10.44	9.13	6.85	3.26	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	64.56	22.55	109.67	1.77	26.09	0.88	1.33	0.44	6.19	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	72.22	24.31	42.82	2.54	13.43	0.71	1.41	0.57	0.99	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	79.67	23.15	26.85	3.45	7.63	0.99	1.35	0.74	1.23	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	60.98	23.10	43.79	2.69	15.04	1.34	0.81	0.27	2.15	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	82.39	22.55	20.44	2.85	6.94	1.24	0.99	0.87	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	87.07	23.53	27.69	4.84	10.38	0.83	2.21	0.55	0.69	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	91.28	29.68	38.42	8.34	13.42	0.20	2.03	1.22	2.24	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	97.89	17.57	20.99	3.19	4.79	0.91	2.05	0.91	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	89.31	16.57	16.82	5.48	5.23	1.00	2.24	0.62	0.75	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	99.23	27.10	17.70	8.52	8.09	1.09	2.19	1.09	1.31	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	116.42	16.25	22.16	5.32	6.80	0.59	1.77	0.00	1.48	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	82.50	15.74	21.46	2.38	6.68	0.79	1.75	0.32	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	87.80	24.80	17.65	4.02	6.48	0.89	0.00	0.89	2.01	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	93.96	7.46	21.78	6.25	3.63	0.00	0.60	0.00	1.41	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	88.72	10.69	23.92	4.24	4.07	0.17	1.02	0.00	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	109.07	20.13	21.19	5.14	7.01	0.09	1.33	0.27	0.44	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	127.47	5.51	21.96	7.49	4.27	0.21	1.04	0.31	0.83	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	137.47	5.29	21.52	7.51	5.98	0.34	0.68	0.68	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	103.46	6.53	18.70	3.98	4.32	0.33	0.55	0.66	0.44	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	97.51	13.48	20.63	5.49	5.99	0.42	0.83	0.33	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	109.24	11.64	19.60	5.51	5.31	1.02	0.82	0.00	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	120.07	6.60	17.12	5.16	4.13	0.62	0.83	0.21	0.41	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	92.58	5.07	15.45	4.61	3.34	0.46	0.92	0.00	0.35	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	113.23	9.51	15.18	5.34	6.34	0.50	0.50	0.17	1.50	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	111.10	5.07	16.31	5.07	2.65	0.44	0.66	0.88	1.76	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	144.15	6.15	19.06	6.40	4.67	0.25	1.60	0.37	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	97.42	10.54	16.05	4.70	6.00	0.49	0.49	0.16	1.13	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	134.38	8.34	14.11	7.38	2.89	0.96	1.60	0.32	1.92	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	139.95	4.45	18.95	8.34	3.13	0.19	1.04	0.38	0.57	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	125.91	2.53	21.20	7.28	6.01	0.16	0.47	0.00	0.63	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	172.72	5.78	15.20	9.73	1.52	0.00	1.22	0.30	0.30	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	144.89	4.81	16.41	6.79	3.03	0.10	0.63	0.00	0.42	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	172.13	5.05	21.52	9.22	5.49	0.88	1.10	0.22	1.76	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	141.68	5.33	12.91	8.14	2.81	0.28	1.40	0.56	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	184.06	3.43	8.52	8.89	2.31	0.00	1.48	0.09	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	196.27	4.01	14.17	12.30	5.35	0.27	0.53	0.27	0.80	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	169.07	3.21	9.79	10.40	4.28	0.31	0.61	0.15	0.31	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	174.10	3.63	12.57	7.64	5.05	0.52	0.65	0.00	0.26	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	244.51	3.25	23.85	12.47	7.59	0.00	0.27	0.27	1.63	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	176.06	5.35	10.14	11.61	1.66	0.18	0.92	0.00	0.18	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	201.55	7.68	7.90	11.18	2.41	0.22	0.66	0.66	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	243.97	7.93	11.90	3.97	1.98	0.00	0.00	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	150.25	7.52	7.65	5.67	2.24	0.53	0.79	0.13	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	112.18	5.65	3.23	5.45	1.41	0.40	0.81	0.20	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	327.61	5.85	17.03	15.25	1.78	0.51	0.25	0.25	1.52	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	50.96	16.92	52.95	4.38	18.51	1.19	0.40	0.80	0.40	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	79.35	28.97	45.30	2.62	12.48	1.39	1.23	0.31	1.39	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	72.01	18.00	63.01	3.27	21.69	0.61	0.61	0.61	2.05	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	65.09	7.82	108.90	5.32	26.91	0.94	0.63	0.00	6.26	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	52.56	6.22	104.83	3.96	29.10	0.57	0.85	0.28	2.83	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	55.81	14.30	77.02	3.23	21.22	1.38	0.92	0.00	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	98.99	24.75	54.45	9.90	17.32	0.00	0.00	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	151.63	22.05	84.32	9.28	25.53	1.55	2.32	1.55	4.25	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	117.13	25.67	80.22	8.02	27.28	0.00	1.60	0.00	3.21	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	166.93	10.43	86.94	12.17	15.65	3.48	3.48	0.00	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	140.61	8.14	69.00	5.86	13.02	1.95	1.95	0.65	3.91	2.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	112.01	11.94	65.48	7.82	16.06	1.24	2.47	0.41	2.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	103.30	23.33	83.31	3.33	16.66	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	118.85	9.23	63.76	7.83	13.70	1.40	1.68	0.28	1.40	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	138.25	7.52	49.03	4.58	16.34	0.98	2.29	0.33	2.61	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	88.08	10.07	62.07	5.03	19.29	1.68	2.52	1.68	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	92.56	9.86	46.44	3.50	14.95	1.59	1.59	0.00	3.50	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	90.35	7.47	50.61	6.11	14.61	1.02	0.68	0.68	0.68	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	85.61	18.79	60.56	6.26	12.53	2.09	2.09	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	69.87	4.58	38.37	3.44	10.88	0.00	1.15	0.00	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	69.26	4.14	34.93	3.26	9.18	0.00	0.59	0.30	1.78	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	57.60	10.16	38.97	3.39	6.78	0.00	1.69	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	84.91	5.38	42.25	2.07	15.74	0.41	0.41	0.00	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	52.93	3.91	37.28	1.61	9.90	0.69	0.23	0.23	1.61	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	10.54	42.15	5.27	31.61	0.00	0.00	0.00	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	76.50	7.30	34.60	3.84	6.54	0.77	0.77	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	53.13	4.24	30.64	2.61	5.54	0.33	0.33	0.00	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	58.19	4.68	23.41	4.01	7.36	1.34	2.68	0.00	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	67.04	7.32	31.59	6.16	4.62	1.16	2.31	0.77	1.54	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	144.81	16.77	23.96	5.48	14.04	0.68	1.37	0.68	1.37	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	64.60	9.94	42.24	0.00	9.94	7.45	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	50.02	4.72	32.09	2.36	8.02	0.47	2.36	1.42	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	65.78	8.45	29.57	4.83	5.43	1.81	4.22	1.81	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	73.25	11.70	34.08	3.05	6.61	0.00	3.05	1.02	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	53.05	5.18	30.31	5.58	4.79	1.60	1.99	0.80	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	84.86	13.81	28.12	4.93	4.93	1.97	1.97	1.97	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	102.70	10.62	33.05	1.18	10.62	1.18	7.08	2.36	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	69.43	9.92	23.92	3.50	3.50	0.58	1.17	1.75	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	94.36	16.68	23.26	3.07	10.09	2.63	4.83	2.63	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	80.53	11.02	27.13	3.39	12.72	1.70	1.70	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	57.90	5.97	14.92	1.19	4.18	0.00	1.19	0.00	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	54.35	4.37	19.41	2.91	4.85	0.49	0.49	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	44.51	4.57	1.14	4.57	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	83.16	2.08	2.91	5.41	1.25	0.42	0.00	0.00	0.42	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	64.09	2.25	4.50	3.37	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	29.50	6.66	1.27	1.90	0.00	1.59	0.00	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	26.74	2.92	1.67	1.25	0.42	0.84	0.42	1.25	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	151.20	5.80	86.22	8.24	28.08	0.23	0.58	0.35	4.29	1.28
Hep-2 cells mock treated, biol_rep2	11899-125E9	185.34	5.23	95.20	12.49	29.54	0.51	2.03	0.17	6.25	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	152.43	2.28	86.45	10.24	23.43	0.00	0.00	0.00	4.55	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	162.54	5.57	90.51	7.76	26.34	0.22	0.77	0.22	5.03	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	162.69	4.94	93.27	12.25	30.95	0.00	1.07	0.00	5.16	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	128.31	2.58	75.35	8.83	28.85	0.22	0.43	0.00	3.01	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	132.38	6.23	80.70	6.85	23.54	0.37	0.75	0.00	3.49	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	139.64	4.63	73.77	7.89	26.42	0.17	0.51	0.00	3.60	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	132.31	3.52	66.00	5.45	27.55	0.00	0.00	0.00	3.52	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	36.94	14.55	2.80	3.92	0.56	0.00	0.56	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	113.39	8.22	13.42	7.79	4.33	0.43	0.00	1.30	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	0.00	0.00	2.64	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	54.67	6.35	6.70	1.76	2.47	0.35	0.71	0.00	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	71.92	5.09	2.91	0.00	0.00	0.00	0.73	2.18	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	125.53	3.15	9.62	6.82	4.55	1.05	1.05	0.87	0.52	0.70
Hepatocyte, donor1	11523-119I2	60.53	0.00	0.00	0.00	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	109.89	2.15	4.31	2.15	0.00	0.00	0.00	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	69.33	5.52	6.75	3.07	0.00	0.00	0.00	0.00	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	106.39	19.58	62.66	9.14	13.05	3.92	3.26	0.65	1.31	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	207.12	27.44	33.73	5.24	8.56	0.70	2.45	0.35	1.40	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	62.57	5.49	6.31	4.94	1.92	0.55	0.41	0.27	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	89.15	41.39	114.62	6.37	44.57	9.55	0.00	0.00	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	146.86	26.70	73.43	40.05	40.05	13.35	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	54.17	81.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	103.83	44.30	69.22	13.84	19.38	8.31	2.77	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	127.64	52.56	60.06	27.53	27.53	20.02	2.50	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	94.95	83.08	71.21	0.00	47.47	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	143.52	66.64	107.64	15.38	33.32	5.13	2.56	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	274.25	109.70	95.99	4.57	32.00	13.71	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	164.06	51.98	103.96	9.75	16.24	12.99	4.87	3.25	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	81.70	33.35	73.36	5.00	26.68	11.67	1.67	1.67	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	167.01	58.09	54.46	7.26	18.15	32.68	0.00	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	201.17	74.11	88.67	11.91	29.12	19.85	5.29	3.97	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	83.15	24.39	53.21	12.20	21.06	5.54	3.33	0.00	1.11	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	214.77	62.86	62.86	20.95	41.91	10.48	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	107.08	47.87	80.62	8.19	20.16	5.67	4.41	0.63	1.26	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	114.45	43.31	81.97	13.92	30.93	10.83	3.09	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	29.27	14.63	0.00	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	136.31	56.85	94.32	9.69	20.67	9.04	2.58	1.94	3.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	128.79	57.96	94.99	14.49	19.32	4.83	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	286.76	71.69	95.59	11.95	35.84	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	170.31	58.67	97.79	9.78	24.45	15.48	4.07	2.44	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	201.09	42.82	108.31	13.01	36.94	3.78	1.68	0.42	2.10	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	172.47	100.61	14.37	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	138.23	53.85	88.41	8.04	23.31	2.41	4.82	1.61	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	120.03	38.78	60.94	11.08	24.01	6.46	3.69	3.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	180.97	90.48	45.24	45.24	15.08	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	92.52	28.32	65.61	7.55	12.75	5.66	0.47	1.42	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	69.84	29.02	68.93	9.07	16.33	1.81	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	176.91	73.71	44.23	14.74	29.48	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	110.84	48.43	82.86	9.69	25.83	8.61	2.15	0.00	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	116.88	36.84	87.66	12.70	25.41	1.27	0.00	2.54	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	82.15	98.58	0.00	0.00	49.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	112.23	45.28	83.54	7.01	29.33	3.83	0.64	1.28	1.28	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	92.96	36.45	89.31	9.11	25.52	1.82	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	142.24	47.41	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	117.82	60.70	103.54	9.28	23.56	4.28	0.71	0.71	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	106.19	66.37	89.59	16.59	39.82	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	41.70	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	60.19	33.34	67.91	4.32	17.90	2.47	0.31	0.31	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	75.51	45.66	100.09	8.78	40.39	1.76	1.76	0.00	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	44.00	122.58	0.00	40.86	3.14	6.29	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	75.10	39.64	109.87	3.48	28.51	0.70	2.78	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	177.05	42.05	79.67	24.34	26.56	30.98	6.64	15.49	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	178.31	71.32	97.26	19.45	29.18	25.94	6.48	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	177.00	61.91	117.71	9.59	18.31	18.31	9.59	4.36	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	242.98	67.49	130.49	6.75	22.50	20.25	6.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	156.81	62.72	132.41	13.94	20.91	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	183.49	62.94	120.55	16.00	23.47	18.14	14.93	8.53	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	105.29	56.80	98.37	6.93	19.40	16.63	5.54	4.16	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	105.44	45.59	122.53	17.10	48.44	8.55	2.85	0.00	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	152.79	57.07	113.21	15.65	23.01	21.17	6.44	7.36	1.84	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	220.85	66.56	108.91	12.10	18.15	24.20	0.00	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	254.56	74.50	55.88	0.00	24.83	55.88	12.42	0.00	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	190.33	65.56	96.22	7.40	19.03	25.38	8.46	7.40	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	146.31	7.26	8.98	9.47	3.92	0.08	0.49	0.41	0.24	0.57
Keratinocyte - epidermal, donor2	11349-117G8	395.89	9.96	22.84	19.91	8.78	5.27	1.76	1.17	1.76	0.59
Keratinocyte - epidermal, donor3	11421-118F8	207.11	11.26	24.14	12.78	6.63	2.08	1.14	0.85	0.95	0.95
Keratinocyte - oral, donor1	11251-116E9	320.12	8.29	40.19	21.00	8.40	0.91	1.02	1.14	2.04	0.68
Keratocytes, donor1	11527-119I6	326.30	43.32	7.56	7.56	4.47	18.22	25.10	3.09	1.03	0.69
Keratocytes, donor2	11607-120I5	83.20	4.69	15.23	3.52	2.34	2.34	0.00	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	185.54	8.50	6.32	3.95	1.19	5.14	5.93	0.40	0.20	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	263.75	68.14	0.00	10.99	0.00	0.00	4.40	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	121.90	3.24	25.89	9.71	16.18	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	56.17	10.38	4.96	2.31	0.35	0.58	0.35	0.92	0.23	0.00
Lens Epithelial Cells, donor3	11690-122I7	171.04	2.93	5.95	7.47	2.02	0.71	0.20	1.01	0.20	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	36.17	4.86	4.03	2.61	1.90	0.36	0.24	0.24	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	33.77	7.26	5.02	3.91	2.79	0.84	0.28	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	35.89	4.56	4.41	2.36	1.26	0.31	0.63	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	34.41	4.84	4.84	1.08	2.69	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	39.40	4.10	4.10	3.78	0.63	0.32	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	32.67	4.20	4.85	2.16	0.43	0.54	0.11	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	32.83	5.75	2.87	4.10	2.05	0.41	0.00	0.00	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	37.16	9.10	4.30	3.79	0.76	0.25	0.76	0.76	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	40.54	3.94	4.36	2.25	1.41	0.56	0.28	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	47.46	6.33	2.37	2.77	2.77	1.19	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	38.39	7.76	7.95	3.49	2.13	0.78	0.58	0.58	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	48.14	4.81	5.00	2.04	0.00	0.74	0.74	0.37	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.58	3.14	5.23	2.09	1.39	0.00	0.70	0.35	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	39.12	6.68	3.82	2.62	1.91	2.39	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	42.17	3.16	5.49	1.65	1.37	0.55	0.41	0.27	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	44.65	7.39	4.62	2.77	1.54	0.00	0.92	0.00	0.31	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	34.92	6.86	4.68	3.74	1.87	0.62	0.31	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	42.09	4.76	4.76	2.01	1.65	0.37	0.00	0.73	0.73	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	42.13	4.61	4.28	1.65	1.32	0.33	0.33	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	41.29	5.86	5.56	2.64	0.88	0.88	0.59	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	44.81	4.48	5.97	3.24	1.24	0.00	0.50	0.00	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	41.71	7.27	2.42	1.45	3.39	0.00	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	54.13	9.16	4.31	3.50	2.15	0.81	0.27	0.00	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	40.72	5.75	5.30	1.51	0.91	0.15	0.30	0.00	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	44.58	8.29	3.11	1.04	2.59	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	54.02	12.77	4.82	2.93	1.47	0.42	0.42	0.21	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	39.85	3.76	7.52	1.50	1.05	0.45	0.00	0.15	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	48.15	8.25	8.94	0.69	0.69	1.38	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	51.93	9.22	6.59	3.39	1.69	0.94	0.38	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	38.06	4.03	5.41	2.01	1.27	0.42	0.42	0.32	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	46.52	6.78	4.85	1.94	1.94	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	54.25	8.93	4.63	4.30	2.98	1.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	37.54	4.58	5.45	1.86	1.36	0.50	0.50	0.37	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	28.88	9.63	4.81	2.22	0.74	0.00	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	53.86	9.88	5.68	2.72	1.98	1.98	0.74	0.49	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	39.05	4.67	5.50	2.47	1.37	0.41	0.14	0.14	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	34.74	5.47	4.82	1.93	1.93	0.00	0.00	0.32	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	53.87	10.35	7.91	5.48	2.74	1.52	0.91	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	48.15	6.72	4.90	2.24	0.56	0.56	0.28	0.70	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	36.98	5.33	3.56	2.49	2.13	0.00	0.36	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	75.14	7.27	5.82	5.33	0.97	2.42	0.48	0.97	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	48.71	2.96	5.60	2.33	1.09	0.62	0.00	0.16	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	51.93	6.09	6.45	2.15	1.07	0.36	0.36	0.72	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	57.17	8.49	8.17	3.59	2.94	0.65	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	48.97	4.94	6.83	2.12	0.94	0.47	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	43.07	5.07	5.69	2.35	1.24	0.25	0.62	0.62	0.50	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	69.67	6.92	8.96	4.87	2.82	1.02	0.00	0.51	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	40.58	3.58	3.88	1.79	1.19	0.60	0.00	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	140.49	15.86	38.52	4.53	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	108.17	6.90	22.25	2.30	0.77	1.53	0.00	0.00	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	122.47	6.68	25.24	6.68	3.71	0.00	0.74	0.74	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	134.98	20.31	27.93	5.50	2.54	0.00	0.85	0.42	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	104.09	8.44	24.62	4.92	2.81	0.70	0.00	0.70	2.81	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	111.14	15.88	20.55	1.87	1.87	1.87	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	114.39	14.94	23.19	6.70	2.58	1.03	2.58	0.00	2.58	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	107.05	10.71	30.93	10.71	4.76	2.38	4.76	0.00	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	148.83	12.44	28.05	6.79	1.36	0.90	0.00	0.23	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	103.24	13.09	12.80	6.40	1.16	0.00	1.16	0.29	1.74	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	96.79	10.35	20.71	2.70	1.80	1.80	1.80	0.45	2.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	154.59	12.87	28.05	7.86	2.03	0.68	1.08	0.27	2.03	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	156.11	13.35	23.62	9.76	2.05	0.51	1.03	0.00	1.54	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	110.44	12.70	21.52	7.41	2.12	1.41	0.35	0.35	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	123.93	6.00	16.66	7.33	1.33	0.00	1.33	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	176.76	18.34	27.51	13.75	3.06	1.53	1.53	0.00	2.04	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	118.19	10.14	20.01	4.00	4.27	0.80	1.07	1.07	1.33	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	148.13	13.60	19.46	7.75	1.89	0.57	0.76	0.76	2.08	1.70
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	198.18	12.88	31.91	12.88	3.68	1.23	3.07	0.61	2.45	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	168.79	11.42	39.14	1.63	2.45	1.63	1.63	0.00	4.08	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	137.02	9.79	16.03	6.25	2.29	0.62	2.29	0.62	2.29	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	136.21	12.05	21.02	4.48	3.08	0.56	1.40	0.00	1.12	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	182.37	7.21	26.79	12.36	3.09	0.00	2.06	0.00	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	153.28	9.29	21.19	6.39	3.19	0.58	0.58	0.29	2.03	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	117.48	11.36	19.13	5.98	1.20	0.00	2.09	0.30	1.49	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	114.52	11.07	19.92	4.43	1.11	1.66	1.11	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	167.55	14.14	31.46	10.25	6.01	1.41	1.77	0.71	1.06	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	122.07	15.49	29.13	7.01	2.21	0.74	1.84	0.74	1.48	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	157.72	12.66	32.24	11.51	2.30	0.00	1.15	0.00	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	162.33	13.43	26.10	6.14	4.99	1.54	1.54	0.38	1.54	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	153.42	12.45	35.10	7.36	2.83	0.00	3.40	0.57	3.40	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	110.76	9.85	27.08	3.28	4.10	0.82	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	166.74	10.85	30.73	5.42	2.71	0.90	1.81	0.00	2.26	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	130.70	14.36	26.57	11.49	2.15	0.00	1.44	0.00	2.87	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	110.54	11.95	20.91	2.99	2.24	1.49	0.75	0.75	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	129.31	14.86	30.84	8.55	2.97	0.37	0.74	0.00	3.34	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	94.76	12.06	18.95	6.46	2.15	0.43	0.00	0.00	1.72	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	108.75	10.28	25.69	4.28	2.57	0.00	2.57	0.86	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	108.28	10.99	25.99	8.66	3.00	0.67	1.67	1.00	3.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	138.16	11.46	28.96	6.03	1.21	0.00	4.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	149.31	9.95	34.84	4.27	3.55	0.71	0.00	1.42	4.98	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	133.02	11.00	27.84	3.44	1.72	0.34	2.06	0.34	2.06	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	134.19	11.27	25.23	6.44	2.15	0.00	2.15	1.07	3.76	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	106.39	12.79	28.28	5.39	2.02	1.35	1.35	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	149.27	9.63	25.19	5.19	2.96	0.00	1.11	0.74	1.48	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	157.00	8.14	20.93	8.14	2.33	0.00	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	129.04	4.23	32.79	10.58	1.06	1.06	3.17	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	144.45	12.00	29.61	7.20	0.80	0.80	0.40	0.40	2.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	138.83	18.90	34.89	7.27	5.81	0.00	2.18	1.45	2.91	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	157.14	17.63	26.83	11.50	2.30	1.53	1.53	0.00	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	130.72	16.77	21.70	7.89	4.44	0.49	1.97	0.00	1.48	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	143.02	17.88	22.58	7.53	5.65	0.00	1.88	0.00	2.82	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	157.89	21.62	31.17	8.05	3.02	2.01	0.50	0.50	1.51	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	161.77	10.81	31.99	7.66	2.25	2.25	2.70	0.00	1.80	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	144.57	12.05	32.70	12.05	8.61	0.00	6.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	146.52	14.70	25.38	4.01	2.23	0.89	1.34	0.45	2.23	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	152.50	15.64	25.03	7.43	4.69	1.17	2.74	0.00	2.35	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	177.47	6.60	27.05	12.53	2.64	1.32	3.96	0.00	1.98	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	188.89	16.09	23.87	7.78	2.08	0.52	1.04	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	167.59	7.44	28.00	8.75	4.81	0.44	1.31	0.00	2.19	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	201.84	13.42	29.63	13.98	2.80	0.56	2.24	1.68	0.56	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	198.30	15.02	27.38	6.18	3.97	1.32	0.88	0.00	1.77	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	198.26	11.96	30.86	5.79	3.47	1.16	3.86	0.39	1.93	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	188.36	9.11	22.28	6.58	4.05	2.53	1.01	0.51	1.01	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	246.56	10.57	27.40	9.61	3.84	1.44	2.88	0.48	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	211.49	15.11	27.03	13.91	2.78	0.00	1.59	0.40	1.59	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	230.29	16.41	21.27	11.54	4.25	0.00	1.82	0.61	2.43	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	183.30	13.14	27.67	6.92	2.77	1.38	4.84	0.69	1.38	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	232.55	12.54	26.98	7.22	2.66	0.38	0.38	0.38	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	269.57	11.36	27.37	5.68	5.68	2.58	5.16	1.03	1.03	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	208.61	10.88	31.44	7.86	4.23	0.60	1.21	0.60	1.21	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	201.87	11.09	27.89	8.87	4.44	0.95	1.90	0.00	1.58	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	262.28	20.79	32.52	11.73	2.67	3.20	1.60	1.07	2.13	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	209.75	20.11	32.76	12.07	4.02	1.15	2.30	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	281.80	9.77	42.17	9.77	4.63	1.54	2.06	0.00	1.54	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	227.06	18.39	22.64	10.61	4.95	0.00	1.41	0.00	1.41	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	234.94	14.75	34.05	11.35	5.11	1.70	2.27	0.00	1.70	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	240.46	13.73	31.20	8.32	3.74	0.42	1.66	0.00	4.58	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	246.66	15.66	34.45	7.05	7.05	1.57	2.35	0.78	3.13	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	165.77	10.86	40.50	6.26	3.34	0.84	0.84	0.84	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	220.24	13.94	28.81	7.90	2.79	0.93	2.79	0.00	1.39	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	225.47	20.74	39.47	13.38	4.01	0.67	2.68	0.00	2.01	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	184.99	17.11	39.03	7.48	7.48	0.53	0.53	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	256.20	17.38	38.79	9.70	5.66	0.81	2.42	0.40	2.83	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	242.29	10.10	35.79	12.85	8.26	1.84	0.92	0.92	4.59	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	210.72	21.34	45.34	5.33	8.89	2.67	1.78	0.00	1.78	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	219.97	14.82	38.18	6.84	7.41	1.71	1.14	0.00	3.42	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	247.71	15.34	33.74	14.57	1.53	1.53	0.77	0.77	0.77	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	161.42	11.49	37.76	6.57	5.47	2.19	1.09	1.64	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	232.97	15.15	36.53	12.03	3.56	1.78	0.89	0.45	3.12	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	270.87	17.16	54.59	11.44	5.72	1.30	1.04	0.52	2.08	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	208.88	11.27	57.69	13.93	3.32	1.33	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	203.70	22.86	35.34	6.24	10.39	2.08	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	122.62	9.34	3.19	5.24	0.00	0.68	0.68	0.46	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	103.31	7.52	4.04	7.16	2.02	0.92	0.18	0.18	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	121.12	8.65	6.29	9.83	1.44	1.57	0.66	0.39	0.39	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	242.15	9.03	14.34	11.68	10.62	1.06	0.53	0.00	0.00	1.59
Mallassez-derived cells, donor2	11929-125I3	118.68	6.81	1.90	8.08	2.38	0.00	0.32	0.16	0.16	0.16
Mallassez-derived cells, donor3	11930-125I4	86.17	8.48	9.45	5.84	7.78	0.83	1.11	0.00	0.14	0.56
Mammary Epithelial Cell, donor1	11273-116H4	481.68	38.86	27.10	25.21	6.88	9.47	6.58	2.79	1.20	0.50
Mammary Epithelial Cell, donor2	11350-117G9	426.22	24.90	33.88	31.27	14.77	7.53	4.05	1.16	1.45	1.45
Mammary Epithelial Cell, donor3	11422-118F9	445.97	5.24	36.67	32.18	12.47	1.50	0.75	0.25	2.24	0.25
Mast cell - stimulated, donor1	11487-119E2	31.86	12.20	0.00	1.36	0.00	2.03	0.00	2.03	0.00	0.68
Mast cell, donor1	11563-120D6	84.89	25.85	0.54	4.33	0.11	1.51	0.22	1.08	0.00	0.32
Mast cell, donor2	11565-120D8	156.61	24.96	0.89	9.81	0.30	4.16	1.49	1.19	0.00	0.30
Mast cell, donor3	11566-120D9	115.49	37.37	0.45	13.73	0.23	2.48	0.68	1.58	0.00	0.45
Mast cell, donor4	11567-120E1	167.36	27.48	0.00	12.06	0.00	8.16	1.42	0.89	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	86.83	57.55	0.55	6.54	0.22	2.11	0.67	0.89	0.11	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	194.37	56.62	0.58	14.01	0.58	0.58	0.00	3.50	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	113.57	60.69	0.92	10.21	0.00	1.95	1.15	1.26	0.00	0.11
Mast cell, expanded, donor8	11941-126A6	82.34	46.36	0.67	8.70	0.17	0.50	0.33	1.51	0.17	0.33
Melanocyte - dark, donor1	11502-119F8	14.33	0.50	5.27	0.99	0.30	0.00	0.00	0.00	0.80	0.00
Melanocyte - dark, donor2	11582-120F7	45.68	2.08	2.42	3.46	1.04	1.04	0.00	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	317.15	2.54	34.92	10.29	5.22	0.43	0.94	0.36	2.61	0.00
Melanocyte - light, donor1	11274-116H5	246.59	2.82	9.87	10.34	4.70	0.71	0.94	0.47	0.47	0.24
Melanocyte - light, donor2	11351-117H1	298.24	2.05	12.28	12.97	4.09	0.00	2.05	1.36	1.36	2.73
Melanocyte - light, donor3	11423-118G1	191.66	2.60	15.61	6.07	3.47	0.00	0.00	0.00	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	216.58	4.17	41.75	7.08	5.62	0.10	0.83	0.21	2.08	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	276.47	4.30	35.77	13.45	6.45	0.00	0.54	0.27	2.42	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	184.28	4.29	14.20	6.70	2.41	0.27	0.54	0.27	1.34	0.27
Meningeal Cells, donor1	11493-119E8	66.87	11.04	12.28	5.83	2.11	1.74	0.74	0.74	0.25	0.00
Meningeal Cells, donor2	11573-120E7	62.06	13.64	8.80	4.84	2.64	0.88	1.32	0.88	0.44	0.44
Meningeal Cells, donor3	11654-122E7	52.89	7.25	11.33	4.65	2.69	0.33	0.41	0.41	0.49	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	43.06	5.13	5.13	2.00	0.57	0.57	0.00	0.29	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	96.00	11.87	1.81	3.42	0.91	0.60	0.40	0.70	0.10	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	98.56	19.71	1.31	6.57	0.00	2.63	1.31	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	65.41	19.62	7.85	11.77	1.31	0.00	0.00	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	42.34	0.72	3.59	3.59	3.59	0.72	0.00	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	83.01	8.47	1.06	3.18	0.00	1.06	0.21	0.85	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	70.37	13.57	1.51	4.02	0.00	0.50	1.01	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	53.40	10.77	7.69	3.96	1.32	0.66	0.00	0.88	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	52.60	8.04	10.23	5.11	3.65	0.73	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	46.65	7.57	8.18	5.32	2.86	0.61	0.20	0.41	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	34.07	5.82	1.39	4.29	1.11	0.83	0.14	0.69	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	121.93	9.29	7.43	7.06	3.35	1.86	1.49	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	85.79	7.63	5.13	3.03	1.97	0.79	1.05	0.79	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	110.68	11.87	2.97	5.34	1.78	2.37	0.89	1.48	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	284.94	16.35	7.01	4.67	0.00	0.00	0.00	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	60.20	9.61	4.48	5.76	5.12	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	63.45	6.38	6.38	3.19	1.77	0.71	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	100.70	8.13	6.88	4.69	0.63	0.94	0.31	1.25	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	58.06	4.35	3.63	3.63	3.63	0.00	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	45.61	9.28	0.27	0.80	0.00	1.33	0.27	0.27	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	61.56	11.01	1.00	3.00	0.00	1.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	45.02	5.35	1.23	2.60	0.22	1.23	0.29	0.43	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	87.77	6.75	1.35	4.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	97.03	7.14	1.97	4.93	0.49	1.23	0.49	0.25	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	86.28	5.89	3.53	6.77	1.18	1.77	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	79.51	0.00	3.46	17.29	0.00	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	76.56	6.51	0.62	3.41	0.31	2.48	0.62	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	70.11	5.60	1.24	4.77	0.41	0.83	0.41	0.00	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	94.96	4.63	0.00	23.16	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	78.58	8.01	1.50	5.51	0.00	1.50	0.75	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	73.08	4.19	0.00	8.38	0.47	0.93	0.47	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	58.73	9.14	2.24	3.86	0.20	1.83	0.20	1.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	80.78	7.92	3.17	7.13	0.40	1.58	0.40	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	76.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	74.33	6.19	1.77	6.19	1.77	0.88	0.00	1.77	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	77.89	6.84	3.42	6.08	1.14	1.90	0.00	1.14	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	55.27	1.32	0.00	2.63	0.00	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	67.49	8.91	1.49	3.61	0.42	2.12	1.06	0.42	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	52.49	4.60	1.84	4.60	0.00	1.84	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	51.56	5.66	1.19	2.98	0.30	1.49	0.00	0.30	0.00	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	62.04	5.03	0.00	6.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	58.46	10.54	1.00	4.01	1.00	3.26	0.25	0.50	0.00	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	34.70	2.85	0.95	3.33	0.48	0.24	0.24	0.24	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	63.58	2.76	0.55	6.08	0.00	0.00	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	53.65	12.66	0.23	4.60	0.23	2.07	0.46	0.92	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	40.60	5.26	1.26	4.00	0.63	0.21	0.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	31.59	3.67	1.02	3.06	0.00	0.41	0.41	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	58.57	7.51	0.21	2.15	0.00	1.29	0.86	0.43	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	32.90	4.67	0.44	2.00	0.00	0.67	0.00	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	20.64	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	35.92	5.26	0.44	2.85	0.66	1.75	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	28.90	4.06	1.01	2.53	0.00	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	51.37	1.66	0.00	4.97	0.00	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	35.88	5.16	0.27	2.17	0.54	1.36	0.00	0.27	0.00	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	39.41	4.41	0.88	2.06	0.29	0.88	0.00	0.59	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	41.43	2.18	0.00	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	53.82	2.40	0.96	5.29	0.00	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	40.42	4.00	0.40	7.60	0.80	0.80	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	75.42	5.48	1.37	2.74	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	54.06	3.00	1.00	4.00	0.50	1.00	1.50	0.50	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	55.04	2.04	0.00	4.08	0.00	0.00	0.00	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	62.62	4.38	0.44	5.26	0.00	1.31	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	99.33	2.21	0.00	4.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	80.05	1.28	0.00	3.84	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	68.92	5.95	0.50	3.97	0.25	1.49	0.50	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	74.46	2.09	0.00	2.78	0.00	0.70	0.00	0.00	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	163.53	2.21	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	118.97	3.76	0.34	5.47	0.34	2.05	0.34	1.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	73.52	2.63	0.44	7.44	0.00	1.75	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	131.74	2.84	1.07	7.46	0.00	0.00	0.00	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	126.81	4.49	0.28	8.14	0.56	1.12	0.28	0.84	0.00	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	87.70	3.74	0.83	9.14	0.00	0.42	0.42	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	128.79	0.58	0.00	4.66	0.00	1.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	110.11	6.33	0.60	6.33	0.60	0.90	0.30	0.90	0.00	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	107.27	5.84	0.00	8.77	0.83	3.34	0.83	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	173.25	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	112.67	5.54	0.00	3.69	0.00	1.85	0.00	0.00	0.92	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	120.65	7.97	0.57	7.97	0.57	1.71	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	71.16	3.45	0.28	4.01	0.69	0.97	0.14	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	110.66	2.59	0.00	5.44	0.78	1.30	0.52	0.26	0.00	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	97.81	5.15	0.00	6.86	1.72	0.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	121.32	4.45	0.00	8.26	1.27	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	96.88	4.54	0.53	5.07	1.07	2.40	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	148.47	13.47	1.20	12.87	0.30	1.80	0.30	1.50	0.00	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	70.91	3.25	0.00	2.83	1.13	1.55	0.14	0.28	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	145.24	6.05	1.27	9.24	0.96	3.82	0.32	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	119.19	6.63	1.55	7.52	1.11	1.33	0.44	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	105.80	4.55	0.00	6.07	0.76	0.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	119.32	6.25	0.57	5.97	1.14	3.41	0.85	1.42	0.00	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	142.32	13.52	2.21	5.65	1.72	2.21	0.74	1.23	0.00	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	168.78	1.96	0.65	10.43	0.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	136.13	4.70	1.18	4.70	2.35	2.65	1.18	0.59	0.00	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	130.61	14.99	1.73	11.24	1.44	2.88	1.44	0.58	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	107.57	2.89	0.41	10.72	2.47	0.41	0.00	1.24	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	160.80	5.36	1.19	8.64	2.38	1.79	0.60	0.60	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	180.81	15.07	7.53	0.00	0.00	7.53	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	78.42	5.35	1.78	0.00	0.00	1.78	0.00	0.00	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	97.59	5.59	1.64	3.29	0.00	2.30	0.66	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	94.68	4.21	1.05	7.36	1.05	1.05	1.05	1.05	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	99.63	7.12	1.38	3.95	0.20	2.77	0.79	0.79	0.00	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	164.84	8.38	0.93	9.31	0.93	5.59	0.00	0.93	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	110.78	2.25	1.13	2.25	0.00	1.13	0.75	0.75	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	97.22	5.86	0.53	3.46	0.00	1.86	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	153.48	4.41	1.70	5.43	0.11	2.26	0.68	0.68	0.00	1.02
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	107.56	3.68	0.00	4.42	1.47	5.16	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	75.48	4.03	0.73	1.83	0.00	1.47	0.00	0.73	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	105.78	9.33	1.56	3.11	0.00	6.22	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	66.80	7.48	0.53	1.07	0.00	4.81	1.07	1.60	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	96.60	3.86	0.00	3.86	0.00	7.73	0.00	0.00	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	119.17	4.04	2.02	3.03	1.01	4.04	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	38.37	6.32	0.42	1.69	0.00	2.53	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	160.71	25.88	0.00	1.36	0.00	16.34	4.09	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	36.88	17.17	0.00	1.27	0.00	13.35	2.54	2.54	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	35.63	12.15	0.00	0.81	0.00	8.91	1.62	2.43	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	52.87	6.04	0.00	0.00	0.00	12.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	953.60	97.07	0.00	5.71	0.00	91.36	22.84	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	665.54	75.04	0.00	13.05	6.52	101.14	35.89	6.52	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	356.44	9.50	4.75	9.50	0.00	28.51	9.50	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	389.02	12.55	0.00	0.00	0.00	62.75	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	222.55	15.08	4.74	10.99	2.15	2.37	0.22	0.65	0.43	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	145.81	16.20	1.57	5.75	0.52	1.57	1.57	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	5.34	0.00	1.33	0.67	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	13.36	6.26	0.42	1.67	0.00	1.67	0.42	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	31.37	8.37	1.33	3.04	1.33	0.76	0.00	0.57	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	3.19	1.60	7.98	1.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	0.68	0.68	0.68	0.00	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	47.78	14.70	0.00	7.35	0.00	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.72	7.12	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.04	5.58	0.70	1.86	0.23	2.32	0.00	0.00	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.65	6.22	0.54	1.08	0.00	0.81	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	29.85	5.89	1.05	2.73	0.00	0.42	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00	0.00	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	10.42	8.93	0.99	0.99	0.00	0.00	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	24.63	9.20	0.00	2.44	0.00	1.08	0.27	0.54	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.01	5.67	0.68	1.59	0.00	0.23	0.68	0.23	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.02	6.70	0.49	1.96	0.00	0.33	0.00	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	38.82	5.47	0.55	2.19	0.18	0.73	0.00	0.36	0.00	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	4.24	1.06	3.18	0.53	0.00	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	3.60	0.60	1.80	0.00	1.80	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	38.72	6.24	0.00	1.97	0.00	0.33	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.99	4.55	0.49	0.81	0.33	0.98	0.33	0.00	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	34.04	4.94	0.71	1.94	0.00	0.35	0.18	0.18	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	19.69	2.81	0.70	3.52	0.00	1.41	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.79	5.06	0.00	1.84	0.00	0.46	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.00	5.78	0.64	0.96	0.32	0.64	0.00	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	45.87	11.73	1.03	2.07	0.34	0.69	0.34	0.69	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	98.61	12.64	5.06	0.00	0.00	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	34.31	4.68	0.00	2.90	0.22	0.67	0.00	0.67	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.05	3.39	0.42	2.12	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.89	2.85	0.71	1.19	0.24	0.71	0.00	0.71	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	28.33	9.01	0.86	1.72	0.00	1.72	0.43	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	21.99	9.00	0.67	1.67	0.00	3.33	0.67	0.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	33.81	4.51	0.45	2.71	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.55	5.95	0.79	2.78	0.40	1.59	0.79	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	1.86	0.93	0.00	0.93	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	46.54	9.84	0.38	2.27	0.38	1.14	0.76	1.14	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	31.61	5.54	2.28	0.65	0.00	1.96	0.33	0.00	0.33	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.87	9.59	0.87	0.44	0.00	2.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	44.78	9.05	0.90	0.90	0.00	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	24.69	6.17	0.88	0.00	0.88	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	3.32	0.66	1.33	0.00	0.00	1.99	1.33	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.33	5.46	0.50	1.49	0.00	0.50	0.99	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	25.65	6.89	1.15	0.38	0.38	1.15	0.77	1.15	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	108.58	22.38	1.51	4.84	0.91	3.02	1.51	1.81	0.91	2.12
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	52.60	7.07	1.11	2.87	0.22	1.33	0.22	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	33.88	6.78	0.68	0.68	0.68	0.68	0.00	0.00	0.00	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	20.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	25.00	7.93	0.61	1.83	0.00	3.05	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	27.70	5.67	0.31	2.83	0.63	1.26	0.00	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	19.98	6.96	0.61	1.82	0.30	0.61	0.30	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	33.23	6.33	0.00	2.37	0.79	1.58	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	89.56	31.74	0.00	7.94	0.00	2.27	0.00	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	10.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	64.72	16.65	2.98	2.24	1.49	0.62	0.12	0.62	0.25	0.62
Myoblast, donor2	11322-117D8	49.67	16.49	4.22	4.22	0.77	1.15	0.38	0.19	0.00	0.38
Myoblast, donor3	11398-118D3	42.04	8.91	2.86	3.53	0.67	1.01	0.34	1.01	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	192.49	24.95	2.92	3.36	1.31	6.13	2.48	3.79	0.29	0.15
Natural Killer Cells, donor1	11230-116C6	122.39	15.07	0.31	4.31	0.92	3.38	0.00	0.31	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	130.27	16.59	1.51	1.51	3.02	3.92	0.60	0.00	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	120.19	14.91	0.37	6.07	1.66	3.31	0.92	0.00	0.00	0.18
Neural stem cells, donor1	11275-116H6	61.70	29.76	3.99	3.27	0.73	0.00	1.09	0.36	0.36	0.00
Neural stem cells, donor2	11352-117H2	92.43	13.48	3.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	127.44	12.52	4.55	4.55	0.00	0.00	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	66.71	6.83	13.65	5.94	1.32	0.66	1.10	0.44	0.66	0.66
Neurons, donor3	11655-122E8	76.46	13.15	9.04	2.47	2.47	2.47	1.64	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	25.06	1.86	0.00	1.86	0.00	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	20.29	0.00	0.00	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	17.10	10.38	0.00	0.61	0.00	1.22	0.00	0.00	0.00	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	56.99	3.09	1.90	3.92	0.71	0.59	0.59	1.07	0.00	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	18.88	4.56	1.30	2.93	0.00	0.33	0.00	0.33	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	73.60	3.61	1.20	6.62	1.00	1.20	0.40	2.01	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	63.04	5.64	0.41	3.85	0.00	2.48	1.24	1.24	0.00	0.55
Olfactory epithelial cells, donor2	11934-125I8	101.32	13.61	1.16	6.66	0.43	0.72	1.30	0.72	0.14	0.87
Olfactory epithelial cells, donor3	11935-125I9	81.38	14.19	0.45	3.18	0.34	2.61	0.23	0.91	0.00	0.34
Olfactory epithelial cells, donor4	11936-126A1	49.58	9.16	2.43	3.02	0.39	1.17	0.10	0.68	0.10	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	103.51	8.43	14.44	2.41	2.41	2.41	0.60	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	74.23	3.19	1.49	5.74	0.43	1.28	0.85	0.64	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	120.03	9.14	1.14	4.57	1.14	2.29	1.14	1.14	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	318.42	14.28	3.72	9.93	0.62	6.83	2.48	0.62	0.00	0.62
Osteoblast, donor1	11277-116H8	192.51	10.94	8.60	11.53	3.13	4.30	2.74	1.95	0.39	0.39
Osteoblast, donor2	11354-117H4	120.10	6.32	7.02	6.32	5.62	0.70	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	119.61	3.73	3.91	7.64	3.02	1.78	0.00	0.71	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	44.81	11.79	1.01	3.87	0.34	0.93	1.01	0.93	0.08	0.00
Pericytes, donor1	11491-119E6	137.41	14.58	2.78	7.90	0.67	2.11	1.22	1.78	0.22	0.11
Pericytes, donor2	11571-120E5	86.02	12.90	2.26	5.43	0.23	2.26	1.13	0.68	0.00	0.23
Pericytes, donor3	11652-122E5	184.73	11.39	10.38	8.95	3.87	1.42	0.61	0.61	0.41	0.81
Perineurial Cells, donor1	11499-119F5	80.81	14.69	4.63	4.86	1.24	1.92	0.23	0.79	0.45	0.23
Perineurial Cells, donor2	11579-120F4	32.48	2.39	3.50	1.47	0.37	0.55	0.28	0.28	0.28	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	86.38	9.24	0.96	3.51	0.64	1.27	0.00	0.00	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	85.70	7.84	0.98	3.18	0.98	2.69	0.24	0.00	0.00	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	77.65	8.80	1.04	2.07	0.13	0.13	0.39	0.00	0.00	0.39
Placental Epithelial Cells, donor1	11278-116H9	734.72	20.33	12.68	16.74	8.85	6.70	4.78	2.15	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	375.91	8.87	11.09	16.63	8.87	1.11	5.54	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	161.38	4.71	8.44	8.05	6.48	2.36	2.36	2.55	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	104.11	5.70	0.32	4.43	0.00	1.90	1.58	1.27	0.32	1.58
Preadipocyte - breast, donor1	11467-119B9	128.87	13.32	0.75	7.88	0.19	1.50	0.94	1.69	0.19	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	200.10	41.77	0.91	6.27	0.26	3.65	1.04	0.78	0.13	0.91
Preadipocyte - breast, donor2	11328-117E5	147.02	12.16	0.45	6.75	0.45	3.38	2.03	0.68	0.00	0.45
Preadipocyte - omental, donor1	11468-119C1	133.84	14.49	1.17	6.93	0.32	1.70	1.07	0.96	0.00	0.43
Preadipocyte - omental, donor2	11329-117E6	72.89	15.28	2.18	3.49	0.00	0.87	0.44	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	104.43	10.31	2.44	5.01	0.29	2.01	0.72	0.43	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	67.91	11.81	0.98	2.95	0.00	0.98	0.98	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	104.73	7.68	3.07	7.68	4.61	0.92	0.00	0.61	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	46.04	7.44	4.96	2.48	3.01	0.53	0.18	0.35	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	54.32	11.07	1.70	2.89	1.70	0.68	0.17	0.68	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	42.29	9.59	2.70	2.51	1.68	1.02	0.19	0.28	0.00	0.09
Preadipocyte - visceral, donor2	11357-117H7	38.66	7.36	2.76	5.52	1.38	0.00	0.00	1.38	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	28.42	5.96	3.55	2.72	1.36	0.10	0.21	0.10	0.10	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	254.64	13.12	53.55	6.18	18.25	0.60	2.56	1.06	1.66	0.91
Prostate Epithelial Cells, donor2	11331-117E8	143.00	7.04	2.57	8.26	1.49	0.27	0.95	0.14	0.14	1.08
Prostate Epithelial Cells, donor3	11404-118D9	301.29	33.19	10.84	11.82	4.65	2.45	1.41	2.20	0.61	0.80
Prostate Stromal Cells, donor1	11254-116F3	189.53	15.72	11.16	9.57	4.67	2.39	1.82	1.03	0.34	0.46
Prostate Stromal Cells, donor2	11332-117E9	118.70	21.34	4.48	7.71	1.61	2.51	2.33	0.72	0.36	0.72
Prostate Stromal Cells, donor3	11405-118E1	70.59	9.70	1.04	4.90	0.52	1.88	0.73	0.63	0.21	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	173.73	9.85	12.04	8.39	2.92	1.46	2.19	1.09	0.73	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	62.24	3.53	4.64	4.37	2.01	0.21	0.14	0.76	0.28	0.07
Renal Epithelial Cells, donor1	11517-119H5	100.94	3.04	14.20	7.61	6.09	0.00	0.51	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	58.33	5.69	9.25	9.96	4.27	0.71	0.71	0.71	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	28.05	2.33	3.81	3.39	1.80	0.21	0.00	0.00	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	51.74	9.53	6.13	2.72	1.36	2.04	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	41.78	12.80	11.45	4.85	2.43	0.40	0.40	0.54	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	58.17	4.22	6.88	2.66	2.89	0.67	0.00	0.44	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	55.90	15.31	5.32	2.66	2.00	0.00	1.33	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	57.00	3.96	6.60	6.16	3.96	0.22	0.66	0.22	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	57.06	4.39	4.39	4.39	3.13	1.25	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	39.95	4.16	4.16	3.05	1.94	0.00	0.00	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	110.05	5.91	12.08	6.71	5.37	0.54	0.54	0.00	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	172.05	8.01	14.76	15.18	3.80	2.53	0.84	0.00	1.69	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	52.45	5.79	9.64	4.63	5.21	0.77	0.58	0.00	0.39	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	235.17	3.89	34.48	15.82	7.26	1.30	0.52	0.52	1.30	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	186.18	7.11	23.59	18.19	6.54	0.28	0.57	0.00	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	166.72	6.17	32.93	16.47	11.32	1.03	0.00	0.00	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	289.55	3.26	14.30	14.05	2.01	1.00	2.76	1.51	0.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	134.57	24.32	4.41	6.01	3.34	0.94	0.53	0.40	0.00	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	105.42	61.64	13.40	8.04	7.15	6.25	1.79	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	89.16	62.19	17.06	3.30	13.76	2.20	0.55	0.00	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	63.81	33.06	17.98	3.48	6.38	0.58	1.16	1.16	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	52.79	19.76	10.79	5.59	5.98	0.65	0.00	0.13	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	51.84	17.38	12.21	3.77	7.94	0.30	0.40	0.50	0.10	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	77.41	23.65	14.05	6.92	10.04	0.56	0.22	0.56	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	79.39	18.36	12.28	4.96	7.44	1.74	0.12	0.00	0.25	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	65.50	18.88	12.35	4.31	8.27	1.05	0.93	0.00	0.12	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	55.24	19.42	16.41	4.62	10.63	1.39	0.23	0.00	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	55.04	18.62	9.31	3.70	6.30	1.23	0.27	0.82	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	65.05	18.00	12.56	3.93	9.23	1.06	0.45	0.30	0.61	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	91.92	21.86	22.76	4.84	11.47	0.90	0.18	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	60.54	18.08	14.78	2.73	6.31	1.58	0.14	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	65.78	17.71	11.48	3.97	9.23	1.50	0.54	0.32	0.32	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	68.81	11.95	17.26	5.97	8.63	0.66	0.66	0.66	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	54.87	18.93	9.18	3.25	7.26	1.72	0.19	0.38	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	65.77	14.53	9.04	3.07	6.34	1.21	0.09	0.56	0.28	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	60.32	22.36	12.03	3.57	10.33	0.56	0.38	0.19	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	58.13	14.60	8.23	4.11	6.10	1.33	0.00	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	56.56	17.81	10.32	3.02	6.52	1.07	0.29	0.58	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	65.12	22.53	16.80	4.20	7.64	0.57	0.19	0.19	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	54.36	16.87	8.22	4.16	5.45	1.17	0.11	0.11	0.53	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	64.47	22.14	7.01	6.17	6.17	1.12	0.00	0.00	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	59.64	16.06	11.11	3.25	7.18	0.85	0.34	0.17	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	61.63	15.50	10.03	5.11	6.20	0.91	0.00	0.00	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	59.48	17.05	8.09	3.31	6.99	1.23	0.37	0.37	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	76.43	18.94	14.37	4.16	10.34	0.81	0.13	0.54	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	68.17	20.76	10.61	6.13	7.31	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	61.71	19.64	8.33	4.76	7.14	1.19	0.60	0.20	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	66.18	16.14	17.07	3.27	9.35	0.47	0.23	0.00	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	57.64	13.48	10.99	3.53	5.60	0.41	0.41	0.00	0.21	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	72.34	15.48	10.62	5.75	8.85	1.11	0.88	0.22	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	58.49	11.91	15.25	4.80	9.40	0.84	0.42	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	58.41	13.05	12.11	4.04	6.19	0.40	0.27	0.27	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	68.29	11.58	9.71	4.94	7.15	0.51	0.00	0.34	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	60.15	14.07	13.30	3.08	6.94	0.39	0.00	0.19	0.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	49.69	18.40	9.63	3.27	5.16	0.69	0.34	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	53.63	14.13	7.41	3.02	5.21	0.27	0.14	0.14	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	49.25	15.92	12.15	4.27	7.55	0.66	0.00	0.49	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	29.65	11.93	8.86	2.22	5.62	0.68	0.00	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	39.95	12.58	9.03	1.92	4.59	0.59	0.00	0.15	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	37.85	12.79	10.93	2.40	4.53	1.07	0.53	0.00	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	100.93	31.25	9.68	10.23	6.36	5.53	1.24	1.80	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	39.52	10.95	13.81	3.10	3.57	0.00	0.00	0.00	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.61	16.73	11.29	1.41	6.25	0.00	0.20	0.00	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	63.57	29.19	12.90	3.39	4.14	2.64	0.28	1.13	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	143.94	30.74	19.91	9.78	4.54	2.45	1.40	0.35	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	107.89	29.31	6.95	5.74	3.32	5.44	0.30	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.98	21.66	11.38	3.30	5.39	2.20	0.73	0.24	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	160.98	92.72	11.06	9.61	9.17	3.64	2.04	0.87	0.15	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	194.09	57.80	19.47	6.08	6.69	3.04	1.83	0.61	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	50.33	19.29	10.25	3.01	5.43	1.51	0.00	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	199.05	41.39	19.68	10.18	9.05	2.94	1.13	0.45	0.68	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	149.47	87.77	14.68	7.79	9.88	4.19	1.80	0.60	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	188.92	43.45	21.61	10.27	10.51	6.38	2.48	1.77	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	182.71	36.50	27.53	9.61	14.09	3.20	2.35	1.92	0.43	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	138.83	88.94	22.24	10.82	15.02	2.40	2.40	0.60	0.00	1.20
Schwann Cells, donor1	11498-119F4	70.90	8.46	8.28	9.40	2.07	2.63	1.50	1.50	0.56	0.38
Schwann Cells, donor2	11578-120F3	95.27	3.40	13.61	6.80	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	56.52	2.19	1.31	6.35	1.10	0.66	0.44	0.00	0.00	0.22
Sebocyte, donor1	11220-116B5	227.32	8.76	23.01	10.96	9.31	0.55	2.19	0.00	1.64	0.00
Sebocyte, donor2	11301-117B5	196.69	9.65	38.60	7.81	20.68	1.84	0.92	0.00	1.38	0.00
Sebocyte, donor3	11378-118B1	76.88	13.81	6.39	3.92	2.68	2.06	0.82	0.62	0.21	0.41
Sertoli Cells, donor1	11255-116F4	107.68	9.94	0.00	4.97	1.66	0.00	0.00	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	56.49	11.30	8.47	8.47	0.00	2.82	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	222.06	11.00	5.19	10.82	2.29	3.34	2.55	3.96	0.09	0.26
Skeletal Muscle Cells, donor2	11358-117H8	521.17	10.84	6.51	20.24	0.72	11.57	2.17	6.51	0.00	2.17
Skeletal Muscle Cells, donor3	11430-118G8	105.34	3.34	14.21	6.69	9.20	0.84	0.84	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	54.51	11.15	11.47	5.50	3.61	0.79	0.47	0.47	0.47	0.63
Skeletal Muscle Cells, donor5	11455-119A6	49.20	7.88	7.73	4.16	2.23	0.74	0.89	0.15	0.00	0.45
Skeletal Muscle Cells, donor6	11459-119B1	56.64	6.31	8.93	3.39	5.23	0.92	0.92	0.31	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	71.82	17.51	4.54	5.29	1.26	1.13	0.25	0.50	0.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	44.23	7.99	2.57	4.14	1.85	0.29	0.29	0.29	0.29	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	62.40	9.13	8.73	5.26	3.77	0.60	0.69	0.60	0.20	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	120.06	8.51	3.37	5.73	1.26	1.85	1.01	1.43	0.00	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	305.43	13.03	18.82	23.16	9.41	8.69	8.69	2.90	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	94.12	3.44	2.48	6.88	1.10	1.10	1.10	0.83	0.00	0.69
Skin - palm, donor1	10286-104F7	209.52	21.49	2.69	21.49	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	72.51	6.49	6.34	6.49	6.78	0.43	0.14	0.43	0.14	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	118.59	224.92	9.81	10.63	17.99	1.64	3.27	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	69.07	8.05	10.78	5.45	7.14	0.65	0.00	0.13	0.39	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	465.54	30.30	15.71	22.38	8.48	4.31	2.92	2.22	0.28	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	326.89	17.58	9.14	10.83	7.03	3.24	1.27	1.27	0.42	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	244.64	162.39	28.12	12.69	13.96	2.75	1.48	0.00	0.85	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	304.30	35.38	8.24	10.94	4.50	3.82	0.90	2.02	0.37	1.35
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.25	8.95	0.00	0.31	0.31	2.47	0.00	0.31	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	180.53	38.69	7.11	15.56	5.34	4.45	0.67	0.89	0.00	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	55.26	5.29	7.05	0.00	4.11	2.94	0.00	0.00	1.76	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	74.03	7.96	3.54	4.86	0.44	1.55	1.10	0.88	0.88	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	63.79	6.30	9.06	3.15	1.58	1.18	0.39	0.79	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	59.49	13.91	6.95	1.55	2.32	1.55	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	54.04	12.01	4.00	2.00	0.00	1.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	36.20	4.52	2.26	2.13	1.33	0.53	0.00	0.40	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	35.02	9.75	2.88	1.55	0.44	0.44	0.00	0.44	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	110.49	12.29	5.38	6.79	2.94	3.58	1.79	1.92	0.38	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	63.16	9.77	4.23	3.26	1.30	0.65	1.30	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	34.55	7.68	3.54	1.77	0.59	0.30	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.60	2.99	1.00	2.28	1.14	0.57	0.28	0.28	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	65.40	5.21	4.72	6.02	1.63	0.49	0.33	0.16	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	220.71	10.66	3.04	9.13	1.22	1.52	1.83	1.22	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	58.85	2.27	5.56	3.54	1.01	0.51	0.00	2.02	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	116.29	12.24	6.12	0.00	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	73.91	7.63	4.77	4.77	5.25	0.95	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	38.49	4.72	2.80	1.77	0.59	0.15	0.15	0.15	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	27.98	7.32	3.01	2.58	1.08	0.86	0.22	0.00	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	35.90	5.98	4.83	1.99	1.15	0.42	0.52	0.42	0.31	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	58.00	6.34	5.57	3.09	2.32	0.62	0.62	0.00	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	58.21	6.47	7.55	8.62	5.39	3.23	2.16	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.97	4.48	2.09	3.59	1.79	0.30	0.30	0.60	0.00	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	71.01	4.10	8.53	5.80	3.41	0.68	0.34	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	53.87	15.39	2.91	4.32	0.71	1.49	0.31	1.88	0.08	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	26.47	10.57	2.21	1.61	1.01	0.40	0.00	0.10	0.30	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	64.85	10.92	3.19	3.19	1.37	1.37	0.46	0.91	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	71.85	7.85	4.83	5.43	3.02	3.02	1.21	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	59.61	8.21	21.46	5.03	6.89	0.79	0.26	0.26	1.59	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	77.76	15.58	3.20	6.13	0.80	3.46	0.80	0.80	0.00	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	102.43	13.77	3.63	5.76	1.00	1.63	1.88	1.50	0.50	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	67.22	3.55	0.51	4.06	0.25	0.76	0.51	1.27	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	66.79	6.18	4.37	3.47	1.21	0.45	0.15	0.45	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	48.01	5.25	1.50	3.00	0.00	0.75	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	42.64	3.88	7.75	2.58	1.29	0.00	0.00	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	70.69	3.72	8.37	2.79	4.65	0.47	0.00	0.93	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	49.98	13.13	5.55	3.03	2.52	0.50	1.01	0.50	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	48.26	10.34	3.76	2.82	1.57	0.63	0.31	0.00	0.31	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	28.32	3.83	2.65	1.47	1.18	0.88	0.29	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	37.74	3.33	6.66	3.25	1.58	0.25	0.17	0.17	0.33	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	50.92	4.20	0.93	1.40	0.00	0.93	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	46.20	7.48	2.30	2.01	1.01	0.58	0.29	0.29	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	59.91	5.10	7.14	2.55	2.04	0.51	0.51	0.51	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	75.40	3.95	5.64	4.32	2.63	1.88	0.56	0.56	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	33.68	4.33	2.10	1.68	1.26	0.42	0.14	0.14	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	177.30	1.59	4.27	6.28	3.77	1.09	0.42	0.59	0.17	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	205.23	10.00	3.81	15.24	2.38	2.38	0.95	0.95	0.00	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	41.35	5.14	1.22	1.96	0.73	0.49	0.00	0.98	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	33.58	5.08	0.88	1.77	0.66	0.88	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	127.56	12.87	1.76	7.31	2.05	2.34	1.17	0.59	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	68.41	13.99	0.97	1.75	0.39	1.94	0.58	0.78	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	58.71	11.64	0.00	2.64	0.53	2.38	0.53	0.53	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	22.32	13.02	0.00	0.37	0.37	0.74	1.12	1.12	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	52.46	16.89	1.44	2.87	0.00	0.36	0.72	0.00	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	68.14	7.95	1.42	2.27	0.28	0.00	0.28	0.00	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	102.80	16.15	5.12	5.91	3.15	1.18	0.79	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	49.01	10.41	1.02	1.52	0.25	0.25	0.76	0.76	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	25.96	11.58	2.00	3.59	1.20	0.40	0.00	0.80	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	46.40	8.36	0.84	3.34	0.84	1.25	0.84	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	144.38	22.00	1.83	8.25	0.46	1.83	0.92	0.92	0.00	1.83
Synoviocyte, donor1	11291-117A4	68.34	7.74	1.85	2.19	0.34	0.84	0.00	0.50	0.00	0.17
Synoviocyte, donor2	11368-117I9	106.11	8.38	1.84	3.86	0.67	1.68	0.50	1.51	0.00	0.67
Synoviocyte, donor3	11440-118H9	44.46	6.70	0.45	3.35	0.22	0.89	0.67	1.12	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	97.91	8.58	14.29	8.22	4.65	1.43	0.71	0.00	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	331.00	41.62	13.87	17.84	1.98	7.93	27.75	3.96	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	191.95	21.53	18.52	7.64	3.70	9.49	12.74	1.85	0.69	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	278.21	19.00	25.59	15.41	9.82	3.87	1.86	2.15	1.00	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	142.26	8.50	34.40	13.14	12.76	1.16	1.93	1.16	0.77	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	266.86	15.46	41.23	12.03	22.91	13.17	7.44	2.86	1.72	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	148.86	23.87	3.08	7.26	2.83	1.48	0.74	0.62	0.62	0.12
Urethra, donor2	10319-105A4	52.15	5.40	1.80	5.40	0.00	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	286.38	10.36	11.69	16.74	3.98	0.27	0.53	0.53	0.00	0.53
Urothelial Cells, donor2	11600-120H7	133.39	10.41	8.41	5.21	2.80	0.40	0.00	0.80	0.40	1.20
Urothelial Cells, donor3	11681-122H7	193.91	8.94	11.46	5.96	3.21	1.15	0.92	0.92	0.00	0.69
Urothelial cells, donor0	11216-116B1	101.42	4.46	5.80	3.57	1.11	0.89	0.89	0.89	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	48.05	16.02	0.89	0.89	0.00	0.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	50.04	10.01	1.43	7.15	1.43	0.00	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	26.01	6.16	2.05	3.42	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	40.29	6.54	0.69	2.75	0.00	0.00	0.00	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	49.39	5.23	1.74	6.39	0.00	0.00	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	36.44	5.21	2.08	4.16	0.00	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	38.55	8.26	0.00	3.67	0.00	0.92	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	37.43	12.78	1.83	0.91	0.00	0.00	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	39.85	13.45	9.75	2.10	1.73	1.23	0.86	0.49	0.74	0.00
Wilms' tumor cell line:HFWT	10597-108E3	308.89	5.28	13.20	2.64	3.52	0.88	2.64	0.00	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	147.48	16.48	70.39	13.97	15.92	3.63	0.56	0.28	3.07	1.12
achilles tendon, donor2	10292-104G4	134.32	31.00	4.13	6.20	2.07	10.33	0.00	4.13	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	39.01	14.79	59.40	2.55	11.98	1.27	0.76	0.00	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	65.94	13.93	35.99	3.95	3.02	0.23	0.70	0.70	1.63	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	216.17	16.86	48.08	15.31	15.55	6.65	5.22	2.02	1.19	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	75.92	11.16	46.53	8.71	7.62	0.54	0.54	0.82	2.72	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	41.32	11.52	34.29	3.94	8.99	1.69	0.56	0.56	0.84	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	95.38	27.07	17.76	10.79	5.08	2.33	0.42	0.42	0.42	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	234.65	58.53	5.72	24.50	11.71	8.17	1.91	4.08	0.27	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	57.72	7.49	14.54	5.73	6.61	2.64	0.44	0.44	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	48.19	27.36	15.52	6.53	8.58	2.04	1.63	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	70.28	7.77	16.31	7.38	3.49	0.78	0.00	0.39	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	46.74	22.08	30.18	6.07	8.83	1.10	0.55	0.74	0.74	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	93.61	7.80	31.20	3.90	15.60	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	59.02	11.15	22.54	9.30	5.58	0.23	0.46	0.23	0.23	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	100.45	22.78	23.82	10.36	17.35	2.33	0.78	0.78	0.26	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	61.08	26.01	20.16	7.01	9.06	0.88	0.88	1.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	69.25	38.58	8.83	5.11	1.86	1.39	0.46	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	72.38	25.09	6.58	2.47	2.06	1.23	0.41	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	19.95	5.83	8.90	1.84	2.76	1.23	0.00	0.00	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	39.26	15.79	11.52	4.69	1.28	2.99	0.43	2.13	1.28	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	44.28	21.23	12.74	3.94	1.21	0.30	0.30	0.30	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	50.31	18.29	19.50	4.33	3.13	1.20	0.00	0.48	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	61.70	19.38	27.84	6.24	4.90	1.78	0.22	0.45	0.89	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	132.75	26.68	20.68	7.00	10.34	1.33	0.00	0.33	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	143.08	18.58	3.72	13.01	3.72	7.43	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	65.54	35.03	26.74	6.40	7.53	2.64	1.13	1.13	1.51	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	78.07	15.70	16.14	7.41	5.23	2.62	0.87	0.87	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	20.62	13.12	3.75	7.50	0.00	1.87	1.87	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	123.17	26.38	45.69	8.01	2.83	2.35	0.00	0.24	0.94	0.47
adipose tissue, adult, pool1	10010-101C1	69.03	6.83	1.09	5.12	0.16	0.47	0.00	0.16	0.00	0.00
adipose, donor1	10184-103D4	86.20	12.31	37.53	12.31	2.35	0.00	3.52	0.00	3.52	11.14
adipose, donor2	10185-103D5	72.59	50.69	6.89	4.06	1.62	5.68	6.49	4.06	0.81	5.27
adipose, donor3	10186-103D6	85.23	45.20	19.06	4.63	4.63	5.45	6.81	4.08	1.09	1.91
adipose, donor4	10187-103D7	55.47	22.54	44.20	4.33	13.87	2.60	0.00	1.73	5.20	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	9.78	2.21	24.30	1.74	3.79	0.00	0.00	0.00	3.00	0.16
adrenal gland, adult, pool1	10081-102A9	47.29	0.00	0.00	3.64	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	41.09	22.01	17.48	2.00	8.14	0.27	0.27	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	61.81	18.22	26.08	6.07	17.86	2.50	0.71	0.71	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	111.52	9.27	3.25	4.64	3.71	0.70	0.93	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	55.79	6.76	5.41	3.04	1.01	1.01	0.34	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	67.17	8.25	0.29	4.42	0.00	1.77	0.00	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	50.99	15.42	9.49	3.56	3.56	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	77.86	30.62	5.47	3.24	1.01	0.41	0.41	0.20	1.01	0.41
amygdala, newborn, donor10223	10360-105E9	100.70	50.67	7.75	2.58	1.61	3.23	1.29	0.65	0.32	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	237.09	30.43	3.31	7.39	1.66	6.24	1.15	4.46	0.25	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	65.08	20.08	10.59	2.43	28.46	0.88	0.88	1.32	0.00	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	126.27	35.41	10.02	4.01	0.33	0.67	0.33	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	50.60	8.43	0.98	2.75	0.00	2.16	0.78	0.39	0.20	0.39
appendix, adult	10189-103D9	41.14	8.93	6.21	1.16	0.39	0.00	0.78	0.00	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.45	2.06	17.88	2.06	3.78	0.00	0.00	0.00	0.69	0.00
artery, adult	10190-103E1	46.20	4.08	4.08	1.36	0.00	0.00	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	192.96	26.95	9.56	6.95	3.33	2.75	2.17	2.32	0.87	0.00
b cell line:RPMI1788	10427-106D4	71.82	24.98	20.37	4.61	3.57	2.83	0.89	1.93	0.74	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	123.46	10.27	1.94	5.55	0.83	2.50	1.66	1.11	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	137.24	34.14	20.44	4.96	6.85	2.68	1.19	1.79	0.50	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	758.56	26.28	44.69	14.56	17.07	6.19	1.17	1.84	2.85	1.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	97.87	28.52	10.63	8.95	12.86	6.71	1.68	2.80	0.00	0.00
bladder, adult, pool1	10011-101C2	46.06	9.23	0.98	3.59	0.11	0.87	0.22	0.33	0.11	0.11
blood, adult, pool1	10053-101G8	37.65	4.43	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	31.68	11.99	2.57	5.14	0.86	0.00	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	50.61	12.82	0.67	6.75	1.35	0.67	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	49.20	9.23	6.15	4.10	2.05	0.00	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	56.79	6.79	7.02	3.45	5.01	0.56	0.00	0.22	0.22	0.11
brain, fetal, pool1	10085-102B4	69.46	5.34	37.40	8.01	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	676.26	29.07	81.60	27.42	28.08	2.97	1.98	2.64	5.62	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	90.50	37.82	21.10	5.62	6.37	0.37	0.25	0.62	1.37	0.00
breast, adult, donor1	10080-102A8	50.51	9.47	0.63	3.16	0.63	2.53	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	248.49	17.53	94.77	37.86	8.89	3.68	1.91	0.89	11.94	2.03
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	120.60	25.05	40.51	12.06	7.42	1.55	0.31	0.31	2.47	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	33.61	14.50	11.05	6.22	1.38	0.69	0.46	0.46	1.38	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	165.83	11.86	65.61	9.20	5.33	0.48	0.48	0.48	2.66	1.45
carcinoid cell line:NCI-H1770	10703-109H1	52.19	9.40	36.20	5.17	4.23	2.35	0.00	2.35	1.41	0.47
carcinoid cell line:NCI-H727	10735-110B6	142.96	56.66	30.41	7.66	5.36	5.47	3.94	2.63	2.08	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	23.77	4.44	31.06	1.58	2.85	0.63	0.63	0.32	1.58	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	264.31	18.90	22.89	25.29	1.06	5.32	2.13	3.46	1.60	2.13
caudate nucleus - adult, donor10196	10177-103C6	51.81	16.12	4.61	12.66	1.15	1.15	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	75.30	28.28	4.02	2.51	0.00	0.17	0.17	0.00	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	59.60	23.69	5.35	4.58	0.76	0.76	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	124.52	69.22	4.03	3.30	1.46	3.66	2.20	1.10	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	40.79	11.65	11.65	2.91	8.74	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	68.54	12.38	20.28	3.20	2.78	0.21	0.00	0.21	0.00	0.00
cerebellum, adult, pool1	10083-102B2	31.39	7.24	14.83	3.10	7.93	0.00	0.34	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	111.26	52.31	9.13	5.81	0.83	1.66	0.00	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	79.42	8.07	7.31	5.29	2.77	0.50	0.50	0.50	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	76.01	12.43	5.85	3.65	0.73	2.19	0.73	0.00	0.00	2.19
cervical cancer cell line:D98-AH2	10552-107I3	486.70	38.25	160.03	18.26	30.77	3.88	2.01	4.17	6.76	1.01
cervical cancer cell line:ME-180	10553-107I4	539.41	40.93	90.98	16.90	13.75	1.99	0.66	3.15	7.13	0.50
cervix, adult, pool1	10013-101C4	67.09	10.81	1.36	4.62	0.42	0.63	0.00	0.52	0.00	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	221.27	19.23	2.37	5.57	2.37	4.18	1.95	1.67	0.28	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	54.86	11.76	2.61	5.23	1.31	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	143.04	13.05	112.47	8.08	44.49	2.73	3.36	2.24	3.60	0.62
choriocarcinoma cell line:SCH	10785-110H2	178.04	21.93	35.85	5.67	9.73	4.31	6.53	2.71	4.56	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	188.79	17.79	44.12	13.76	20.16	4.03	0.95	1.19	1.66	0.24
chorionic membrane cells, donor1	12238-129G6	81.20	6.27	10.83	3.70	17.10	1.71	0.57	0.57	0.28	1.14
chorionic membrane cells, donor2	12239-129G7	118.92	4.37	13.42	3.68	10.04	1.59	0.70	0.80	0.00	0.80
chorionic membrane cells, donor3	12240-129G8	83.52	7.14	15.39	4.95	24.18	2.20	0.00	1.65	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	77.75	22.22	45.44	8.08	12.12	2.02	1.01	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	50.14	9.03	12.29	3.84	4.99	0.38	0.00	0.38	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	37.80	23.02	11.62	3.38	4.86	2.11	0.63	0.42	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	62.40	44.94	24.91	5.39	6.16	2.05	1.54	0.51	1.03	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	55.63	48.62	25.88	4.60	3.87	2.42	2.18	1.21	1.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	43.37	51.72	25.25	5.50	4.48	1.22	1.02	1.43	0.81	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	81.56	45.94	51.53	3.24	8.54	1.47	3.24	0.00	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	58.38	22.67	28.93	3.39	3.13	2.61	0.26	1.30	0.78	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	208.24	33.83	43.66	24.92	11.43	1.14	3.20	0.91	1.83	1.60
clear cell carcinoma cell line:TEN	10636-108I6	136.55	26.72	16.66	8.33	1.39	1.21	2.08	0.69	1.04	0.17
colon carcinoma cell line:CACO-2	10513-107D9	214.34	14.09	93.90	12.81	15.01	1.83	3.66	1.46	3.66	0.00
colon carcinoma cell line:COLO-320	10420-106C6	36.87	5.70	106.80	3.42	8.74	0.76	0.00	0.38	2.28	0.38
colon, adult, donor1	10082-102B1	22.61	5.95	7.14	1.19	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	81.08	9.52	2.47	3.41	0.35	0.35	0.00	0.12	0.47	0.24
colon, fetal, donor1	10070-101I7	39.55	20.39	1.24	4.94	0.00	1.24	0.00	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	330.01	36.67	4.58	9.17	0.00	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	168.70	167.85	15.30	6.80	7.65	14.87	12.32	6.80	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	107.31	42.71	26.11	4.53	10.87	3.47	2.87	2.26	0.15	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	78.97	40.89	26.23	3.95	13.11	1.55	1.97	0.71	0.85	0.42
corpus callosum, adult, pool1	10042-101F6	87.01	20.23	1.88	3.43	1.33	0.22	0.00	0.11	0.11	0.44
cruciate ligament, donor2	10295-104G7	135.35	21.07	8.92	2.43	1.62	2.43	2.43	3.24	0.00	3.24
diaphragm, fetal, donor1	10069-101I6	21.67	1.61	0.80	0.00	0.00	0.00	0.00	0.00	0.00	1.61
diencephalon, adult	10193-103E4	54.24	8.16	4.32	3.12	2.64	0.48	0.24	0.24	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	32.15	7.12	62.00	3.44	8.04	1.84	0.00	0.23	0.46	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	658.54	95.65	82.57	58.21	12.31	4.87	0.51	2.82	3.33	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	116.27	10.35	11.55	10.83	5.78	2.17	2.41	0.48	0.24	0.24
ductus deferens, adult	10196-103E7	82.23	13.95	2.99	5.98	0.00	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	7.20	1.44	1.44	0.00	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	62.53	24.28	2.94	1.47	0.00	0.74	1.47	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	79.20	9.00	1.07	3.14	0.41	2.56	0.25	0.74	0.08	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	414.61	147.01	67.07	20.43	50.85	61.51	237.17	28.87	0.89	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	72.65	12.75	15.05	7.02	3.58	1.15	2.87	0.43	1.00	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	156.00	15.42	16.65	13.57	2.47	4.93	0.62	3.08	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	127.44	30.57	19.68	6.36	3.63	1.51	1.21	1.21	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	207.79	20.99	13.28	11.42	3.40	4.63	0.93	1.23	0.62	0.31
embryonic pancreas cell line:2C6	10603-108E9	212.78	22.33	13.13	5.25	2.63	2.63	1.31	0.00	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	145.14	7.37	24.47	7.71	5.36	1.34	0.34	0.67	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	294.69	36.25	25.55	15.59	10.69	5.80	1.99	5.80	1.27	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	325.81	14.79	27.66	26.37	1.29	0.00	1.29	0.00	2.41	1.61
epidermoid carcinoma cell line:A431	10426-106D3	378.38	19.68	45.24	15.45	10.00	1.56	0.89	0.78	1.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	262.76	17.71	63.02	11.00	31.79	1.21	0.44	0.88	1.98	0.11
epididymis, adult	10197-103E8	65.93	24.70	1.47	5.65	0.00	0.84	0.84	1.26	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	72.56	15.08	6.39	5.14	1.06	1.42	1.06	1.42	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	91.23	4.72	22.41	5.51	9.44	1.97	1.18	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	168.27	39.84	99.73	6.95	22.80	0.92	1.18	0.52	4.72	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	259.14	91.24	106.10	10.04	24.80	6.69	3.35	3.25	5.41	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	134.77	37.87	90.30	6.83	19.05	0.45	0.34	0.22	5.38	0.78
esophagus, adult, pool1	10015-101C6	41.83	5.31	4.88	4.67	1.17	0.42	0.21	0.11	0.32	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	253.73	14.03	4.26	9.77	1.13	2.25	2.00	1.75	0.00	0.75
eye - muscle inferior rectus, donor1	10272-104E2	94.17	21.73	0.00	4.83	0.00	0.00	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	46.29	14.73	0.00	2.10	0.00	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	43.16	1.49	0.00	4.46	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	89.43	5.73	2.29	3.44	0.00	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	154.48	17.49	4.37	2.91	2.91	4.37	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	60.00	6.61	2.54	1.53	1.02	1.53	0.25	0.25	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	77.06	14.62	13.98	7.95	7.69	1.54	0.38	1.03	0.13	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	71.94	19.94	17.81	5.94	5.94	1.42	0.47	1.42	3.09	0.71
frontal lobe, adult, pool1	10040-101F4	51.42	9.01	12.57	3.00	4.97	0.09	0.00	0.00	0.56	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	135.11	33.63	27.92	5.40	12.01	3.90	1.20	0.60	2.10	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	126.46	16.00	18.20	6.13	18.84	0.82	0.09	0.55	0.37	0.09
gall bladder, adult	10198-103E9	39.11	7.00	2.66	2.66	0.00	0.00	0.00	0.48	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	83.75	25.23	0.00	6.98	1.07	0.00	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	77.69	15.31	0.37	2.24	0.37	0.75	0.75	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	224.52	32.32	16.26	9.29	3.17	1.69	2.32	1.27	0.63	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	247.96	21.66	21.47	7.74	3.87	3.29	1.16	1.35	2.51	0.39
gastric cancer cell line:AZ521	10549-107H9	189.37	20.49	50.50	12.30	8.69	1.48	0.66	0.66	2.62	0.16
gastric cancer cell line:GSS	10560-108A2	124.47	20.13	86.03	28.37	21.97	0.00	2.75	0.00	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	144.84	12.11	28.10	4.11	6.63	0.46	1.60	1.14	0.91	0.91
giant cell carcinoma cell line:LU65	10487-107B1	180.26	40.62	47.85	8.61	43.14	7.23	1.26	3.67	1.38	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	83.84	24.77	7.84	8.68	3.22	3.22	2.52	1.40	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	387.60	64.60	42.15	24.94	9.23	1.25	1.00	1.50	3.24	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	26.92	15.62	3.27	1.79	0.63	0.42	0.32	0.11	0.21	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	24.86	17.70	3.23	0.98	1.69	0.28	0.14	0.00	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	235.10	22.19	30.57	12.25	6.62	3.42	2.87	2.21	1.66	0.33
glioma cell line:GI-1	10413-106B8	244.85	7.03	12.30	9.08	5.27	2.64	1.17	0.88	1.17	0.00
globus pallidus - adult, donor10196	10175-103C4	59.04	12.39	4.37	4.37	0.73	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	102.28	22.46	3.66	3.42	0.49	0.49	0.00	0.00	0.73	0.24
globus pallidus, adult, donor10258	10367-105F7	79.41	10.95	1.37	5.48	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	139.09	49.03	4.26	3.73	1.07	2.66	1.07	1.07	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	215.35	34.26	2.45	7.34	0.00	4.89	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	0.00	10.93	0.00	0.00	10.93	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	94.08	0.00	5.23	10.45	5.23	0.00	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	68.48	5.76	2.56	5.12	0.00	0.00	0.00	0.00	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	61.52	21.12	64.28	2.75	20.20	1.38	0.00	0.00	1.38	0.46
hIPS +CCl2, biol_rep2	14384-156C1	75.91	20.58	64.93	6.40	28.35	0.46	0.46	0.00	2.29	0.91
hIPS +CCl2, biol_rep3	14385-156C2	74.07	28.34	64.41	8.37	17.39	0.00	0.00	0.64	2.58	0.00
hIPS, biol_rep1	14380-156B6	137.98	20.12	68.99	15.81	54.62	0.00	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	87.11	29.49	66.53	5.49	26.06	0.00	0.00	0.00	2.06	0.00
hIPS, biol_rep3	14382-156B8	66.21	19.86	14.35	1.10	9.93	0.00	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	75.86	40.23	9.77	6.32	9.77	0.86	0.57	0.29	0.29	0.57
heart - mitral valve, adult	10205-103F7	31.09	4.19	0.60	0.90	0.30	0.00	0.30	0.30	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	26.41	4.71	0.26	1.05	0.00	0.26	0.00	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	82.43	13.32	3.33	7.49	0.00	1.67	0.00	0.83	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	71.62	15.51	9.18	2.24	2.65	0.82	0.61	0.20	0.82	0.20
heart, adult, diseased, donor1	10051-101G6	41.73	2.98	0.43	3.83	0.00	0.00	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	34.50	3.68	0.92	3.45	0.00	0.00	0.00	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	35.94	4.00	0.92	1.75	0.00	0.00	0.00	0.00	0.31	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	63.25	7.10	0.31	1.23	0.62	1.54	0.00	0.62	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	269.94	13.08	14.27	16.65	8.32	1.19	1.19	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	62.10	6.85	67.29	2.76	12.93	0.22	0.99	0.11	2.98	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	70.64	7.53	71.73	4.49	14.93	0.24	0.85	0.36	3.03	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	65.08	8.99	73.87	3.23	15.66	0.40	0.61	0.10	3.74	0.20
hepatoma cell line:Li-7	10484-107A7	273.92	19.24	19.13	5.00	6.01	6.01	3.23	1.89	1.11	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	63.32	16.98	38.99	3.72	8.44	3.02	1.11	1.71	0.80	0.20
hippocampus - adult, donor10196	10169-103B7	63.40	11.36	4.73	0.95	1.89	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	103.07	36.53	5.31	2.45	0.61	0.82	0.41	0.41	0.20	0.41
hippocampus, adult, donor10258	10374-105G5	55.77	8.96	9.46	2.99	5.48	0.00	0.00	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	72.26	25.03	4.93	1.76	3.52	2.47	1.06	1.06	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	167.84	25.02	157.47	10.38	34.79	1.22	3.66	0.61	12.21	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	84.83	19.83	104.66	4.32	25.53	1.18	1.37	0.20	5.11	2.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	92.16	24.63	117.30	6.09	24.12	0.51	1.78	0.51	7.62	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	64.28	28.76	38.91	4.51	1.69	2.82	1.13	2.26	4.51	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	56.81	26.34	45.96	6.97	5.68	1.03	2.32	2.32	2.07	3.61
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	90.35	33.79	54.66	11.39	7.59	1.52	2.28	2.66	3.42	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	150.06	89.63	29.49	12.26	8.17	6.71	14.60	10.51	0.88	5.26
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	123.66	87.25	28.87	10.99	5.39	3.23	11.42	8.19	1.51	5.60
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	172.25	83.41	30.45	10.01	6.67	9.18	9.59	8.34	3.75	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	131.18	68.20	19.89	7.34	3.55	3.32	2.37	3.79	0.95	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	99.16	63.97	19.93	7.23	4.34	2.57	4.98	3.70	1.77	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	120.52	60.60	24.24	5.39	6.06	2.69	3.37	3.37	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	52.42	18.47	93.11	3.44	20.03	0.94	1.25	1.25	6.26	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	59.94	21.13	105.63	3.93	30.95	1.47	2.46	0.98	4.91	5.40
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	87.28	23.56	116.08	5.24	25.31	0.00	2.62	1.75	4.36	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	56.32	26.54	33.22	5.35	2.86	1.15	1.34	0.95	2.67	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	61.05	19.62	34.89	3.92	6.54	1.31	1.74	1.31	3.49	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	73.46	25.99	37.98	7.00	5.50	2.00	1.00	1.50	1.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	140.35	49.55	8.29	9.42	2.26	4.52	17.52	5.27	0.75	3.96
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	132.78	53.66	13.64	9.09	2.27	4.09	18.19	3.64	0.91	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	147.53	61.39	12.22	6.89	2.51	6.58	12.84	7.20	1.25	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	99.78	51.77	9.14	6.04	1.96	3.10	4.08	2.29	0.49	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	92.32	51.97	7.55	4.35	2.32	2.32	3.48	2.32	0.29	3.48
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	105.22	63.67	8.37	7.77	1.20	3.29	5.08	5.68	0.30	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	92.00	27.16	94.59	4.25	35.66	0.55	1.29	1.11	6.28	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	83.30	19.40	89.29	7.13	26.25	2.00	1.43	0.00	3.71	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	140.87	25.32	136.38	9.80	36.75	2.04	4.90	2.04	8.98	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	84.50	23.59	36.26	7.04	7.04	1.06	2.11	0.00	1.76	4.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	73.48	20.90	33.26	6.33	4.75	1.27	0.95	0.00	1.27	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	123.17	37.22	34.80	9.38	5.75	0.30	4.84	2.12	2.72	5.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	115.84	63.61	11.38	7.76	1.55	5.69	9.31	2.59	1.55	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	102.95	80.36	15.94	9.96	3.32	4.65	10.63	1.33	0.66	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	138.53	80.29	17.70	8.47	3.33	2.57	7.44	4.87	0.77	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	105.58	57.27	14.06	4.60	2.56	2.56	4.09	1.28	0.51	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	99.95	86.32	12.12	9.84	3.79	2.27	3.79	1.51	1.51	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	103.17	62.17	12.10	5.04	5.04	4.03	2.02	3.36	0.34	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	77.04	19.80	87.43	5.80	23.91	0.24	1.93	0.48	5.80	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	110.52	35.65	99.83	3.12	33.87	1.78	3.12	1.34	6.24	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	81.46	26.34	97.07	4.39	29.27	0.98	0.98	0.49	7.32	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	74.88	23.84	36.37	7.95	4.28	1.53	0.31	1.53	2.44	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	191.94	52.05	81.33	16.27	16.27	0.00	13.01	0.00	0.00	42.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	95.64	38.39	43.02	9.60	7.94	2.32	3.97	0.99	3.97	5.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	170.76	96.87	18.61	9.85	4.38	4.93	12.59	6.57	0.55	5.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	157.78	87.21	21.35	9.77	3.26	5.43	13.39	6.15	0.72	4.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	178.65	91.10	18.86	12.81	6.41	4.27	16.01	8.54	0.71	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	106.21	69.22	11.93	7.16	2.39	2.39	1.19	3.58	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	144.23	101.16	20.86	9.62	3.93	2.57	4.74	3.52	0.81	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	114.76	73.28	15.62	6.47	4.04	2.96	2.42	3.77	1.62	1.62
immature langerhans cells, donor1	11904-125F5	114.54	16.95	0.48	6.78	1.70	5.57	0.97	1.21	0.00	0.24
immature langerhans cells, donor2	11905-125F6	104.56	20.60	3.17	9.51	4.75	2.38	0.79	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	63.69	12.11	12.78	3.22	4.26	0.00	0.28	0.19	0.19	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	241.26	7.48	60.80	12.68	7.15	0.33	0.98	0.00	3.25	0.33
kidney, adult, pool1	10017-101C8	155.60	11.51	1.20	4.51	0.10	0.10	0.30	0.40	0.10	0.00
kidney, fetal, pool1	10045-101F9	148.33	11.81	3.47	6.51	0.07	1.27	0.92	0.85	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	82.80	10.79	7.39	4.83	1.99	2.27	0.99	1.85	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	117.51	16.59	23.50	5.25	8.16	2.21	1.38	1.52	0.28	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	242.40	25.87	32.48	9.36	9.17	2.75	0.92	2.94	2.39	0.00
left atrium, adult, donor1	10079-102A7	15.26	1.63	0.54	0.54	0.00	0.00	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	17.70	3.03	0.00	1.01	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	33.93	2.19	38.03	2.19	4.65	0.00	0.55	0.00	3.01	0.55
leiomyoma cell line:10964C	10569-108B2	51.01	13.65	0.72	2.87	0.00	0.72	0.36	1.44	0.36	1.08
leiomyoma cell line:15242A	10570-108B3	61.96	7.07	0.00	5.98	0.54	0.00	1.09	0.54	0.00	2.17
leiomyoma cell line:15425	10571-108B4	51.23	17.73	1.21	4.86	0.73	0.73	0.73	0.24	0.00	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	120.64	12.70	0.00	0.00	0.00	0.00	0.00	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	30.32	11.50	0.00	1.05	0.00	0.00	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	159.50	33.06	19.60	9.09	12.99	2.72	0.94	0.83	0.00	0.71
liposarcoma cell line:KMLS-1	10782-110G8	29.52	12.50	1.25	3.12	0.16	0.78	0.62	0.00	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	38.87	5.73	9.99	1.95	1.22	0.37	0.37	0.61	0.97	0.00
liver, adult, pool1	10018-101C9	63.20	1.46	8.27	1.62	2.59	0.00	0.16	0.16	0.65	0.00
liver, fetal, pool1	10086-102B5	36.69	3.76	3.76	1.88	0.94	0.00	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	60.08	11.52	4.08	2.62	2.62	0.15	0.00	0.00	0.15	0.29
locus coeruleus, adult, donor10252	10165-103B3	100.03	24.73	4.43	3.51	1.66	0.18	0.55	0.18	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	56.43	17.49	4.51	2.54	3.39	0.00	1.13	0.00	0.00	1.41
locus coeruleus, newborn, donor10223	10362-105F2	116.51	47.53	5.05	3.36	2.94	1.68	3.36	2.10	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	574.48	13.15	47.88	37.50	8.44	1.52	0.42	1.80	2.21	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	39.99	7.58	7.58	4.14	0.00	0.00	0.00	0.00	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	117.58	18.19	18.59	7.38	9.10	3.43	0.40	1.58	0.53	0.13
lung, adult, pool1	10019-101D1	68.51	6.73	0.59	4.13	0.24	1.30	0.24	0.35	0.00	0.24
lung, fetal, donor1	10068-101I5	92.76	23.12	3.14	5.71	0.00	2.28	0.29	0.86	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	54.07	15.12	0.92	2.29	0.00	0.46	0.00	0.00	0.46	0.46
lymph node, adult, donor1	10077-102A5	35.98	1.89	1.42	2.37	1.42	0.47	0.47	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	47.56	13.37	23.67	1.53	14.68	0.22	0.22	0.00	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	12.98	0.15	43.92	0.75	5.43	0.00	0.00	0.00	0.75	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	596.35	53.52	6.80	14.44	6.80	5.95	4.25	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	51.06	4.00	1.33	3.55	0.44	0.00	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	64.13	6.43	0.42	2.08	0.21	0.42	0.00	0.21	0.00	0.00
mature adipocyte, donor3	12233-129G1	58.79	5.69	0.71	2.13	0.00	0.95	0.00	0.24	0.00	0.71
mature adipocyte, donor4	12234-129G2	76.07	3.16	0.53	4.21	0.26	0.53	0.53	0.00	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	297.11	126.28	34.55	26.45	8.34	2.14	0.71	1.67	1.67	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	29.33	9.02	4.51	2.26	6.77	0.00	0.00	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	65.84	20.97	11.22	1.84	4.23	0.37	0.37	0.00	0.37	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	37.80	9.53	9.53	3.49	4.13	0.32	0.00	0.00	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	114.30	26.87	8.10	5.12	2.13	3.84	2.99	2.13	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	39.32	9.11	13.33	2.03	3.04	0.17	0.68	0.17	0.00	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	82.34	22.07	7.85	3.82	2.97	0.21	0.00	0.21	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	67.42	5.78	21.19	3.85	11.56	0.00	0.00	0.00	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	0.00	28.71	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	91.53	37.33	8.61	5.03	0.36	3.23	1.08	0.72	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	79.82	24.66	1.30	3.24	0.00	1.30	0.00	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	105.73	30.65	3.56	4.33	1.55	0.93	0.15	0.15	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	101.22	14.77	3.67	4.49	2.69	0.82	0.16	0.16	0.33	0.16
medulla oblongata, newborn, donor10223	10361-105F1	126.72	57.98	2.78	3.82	2.08	1.39	2.08	1.39	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	123.77	18.38	82.81	7.75	20.15	1.77	2.21	1.55	1.77	0.89
medulloblastoma cell line:ONS-76	10759-110E3	31.91	6.11	26.04	2.57	6.60	0.61	0.24	0.00	1.59	0.00
melanoma cell line:COLO 679	10514-107E1	417.30	18.40	17.11	15.52	3.88	4.74	5.32	1.44	0.14	1.15
melanoma cell line:G-361	10465-106H6	198.44	5.43	4.34	7.33	1.09	1.90	1.36	0.27	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	110.71	34.73	7.06	3.44	1.09	2.71	1.27	1.45	0.18	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	38.77	11.46	32.60	0.88	0.88	0.88	0.00	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	48.47	8.55	42.25	3.37	4.15	0.26	0.26	0.00	1.30	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	65.52	7.06	1.53	5.52	1.38	2.15	0.31	0.46	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	266.31	9.82	3.82	9.63	1.45	6.54	1.82	2.00	0.18	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	69.16	7.45	4.56	4.97	3.73	2.07	0.00	2.48	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	37.51	5.62	1.12	1.83	0.70	1.12	0.00	0.56	0.00	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.99	5.01	1.35	2.89	0.96	0.96	0.58	0.58	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	54.14	9.72	0.69	6.94	0.69	1.39	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	548.03	11.67	6.01	19.57	2.57	4.29	2.40	3.09	0.34	2.06
mesenchymal precursor cell - cardiac, donor2	11753-123G7	70.50	8.97	2.99	4.37	0.46	1.38	0.35	0.69	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	49.08	6.63	2.65	3.05	0.27	1.06	0.80	0.27	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	52.80	7.16	1.76	3.11	1.35	1.62	0.00	0.27	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	40.69	3.41	2.56	3.13	1.99	1.00	0.28	0.00	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	417.95	20.09	1.32	23.38	3.29	2.63	0.99	0.66	0.33	2.63
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	47.18	5.26	0.97	3.32	0.97	0.69	0.42	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.20	2.09	1.75	3.14	0.70	0.35	0.00	0.35	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	56.55	5.92	1.22	3.67	0.61	0.61	0.41	0.41	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	135.87	15.10	2.52	4.67	1.44	1.08	0.36	0.72	0.72	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	27.31	3.72	0.41	1.55	0.10	0.83	0.00	0.21	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	32.83	5.70	0.68	0.46	0.23	0.23	0.23	0.46	0.00	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	48.67	6.29	5.87	2.52	2.94	0.42	0.00	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	49.61	8.37	1.20	4.48	0.45	1.05	0.30	0.45	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	119.30	5.34	2.63	5.69	1.75	1.49	0.61	0.70	0.09	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	218.69	12.89	4.05	12.89	0.74	1.10	0.00	1.10	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	72.97	6.58	2.86	2.58	0.29	1.72	1.14	0.29	0.00	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	80.41	13.05	12.63	6.32	5.89	0.42	0.42	0.00	0.84	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	99.55	9.13	1.37	8.22	0.91	2.74	0.46	1.83	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	124.31	13.30	2.05	5.37	1.28	3.33	0.51	1.28	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	116.74	11.26	1.31	6.02	1.57	4.19	0.26	1.05	0.26	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	116.76	13.25	1.23	8.32	0.31	2.77	0.92	1.85	0.00	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	112.03	17.89	1.41	7.30	0.00	1.88	2.12	0.71	0.24	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	128.95	12.86	1.02	9.14	0.68	2.37	1.69	1.02	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	126.93	28.29	1.96	6.68	0.79	2.36	1.18	1.18	0.00	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	125.11	19.93	3.24	7.41	1.39	0.93	2.32	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	131.81	17.59	1.15	4.90	1.15	1.44	2.88	0.00	0.29	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	109.99	18.74	1.56	7.36	0.45	1.34	1.12	0.67	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	114.17	17.31	2.40	9.85	0.72	0.72	1.20	1.44	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	96.80	14.67	2.20	7.33	0.00	1.47	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	103.05	17.12	3.69	6.38	0.67	2.01	0.67	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	120.36	18.83	0.41	7.37	1.64	2.05	1.23	1.23	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	112.97	16.75	2.15	7.73	1.29	0.86	1.29	0.43	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	98.44	19.14	0.00	8.20	2.73	0.00	2.73	2.73	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	118.79	30.99	0.00	10.33	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	98.41	11.04	0.65	5.52	1.30	0.00	0.00	2.92	0.00	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	100.39	13.09	4.36	7.27	0.00	0.00	0.00	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	101.82	15.46	2.13	5.33	1.60	2.13	1.60	1.60	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	69.51	10.63	2.45	6.54	0.82	0.00	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	85.13	8.94	1.55	5.44	0.78	1.17	1.94	0.39	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	73.46	12.59	8.39	6.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	80.47	10.93	0.00	3.97	1.99	0.00	2.98	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	4.77	0.00	4.77	0.00	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	74.12	7.71	0.00	3.56	0.00	0.59	0.59	1.19	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	96.26	19.50	1.22	7.31	0.00	0.00	0.00	0.00	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	81.71	15.20	0.63	6.33	0.63	1.90	2.53	0.63	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	83.12	15.87	1.38	4.83	0.00	2.41	0.00	1.03	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	73.07	21.49	6.45	4.30	0.00	2.15	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	115.76	11.98	3.99	0.00	3.99	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	103.32	13.78	0.00	3.44	0.00	3.44	0.00	0.00	0.00	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	119.39	25.26	1.22	4.48	0.81	2.85	1.63	1.63	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	125.52	19.86	5.56	3.97	0.79	3.97	0.00	2.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	73.10	11.20	1.77	1.77	0.59	0.00	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	88.21	12.47	2.49	2.81	1.25	0.62	1.25	0.62	0.00	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	88.22	10.69	0.00	4.01	0.00	2.67	1.34	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	46.12	3.55	1.18	4.73	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	61.63	2.57	5.14	2.57	0.00	0.00	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	57.14	6.20	1.38	2.07	0.00	0.00	0.69	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	31.17	2.47	1.48	2.97	0.00	0.99	0.00	0.49	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	24.67	2.24	1.12	4.49	0.00	0.00	0.00	0.00	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	28.62	5.09	2.54	1.27	0.00	0.00	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	51.58	6.04	2.82	2.42	0.00	2.42	1.21	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	58.88	6.54	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	58.28	6.34	2.53	1.27	1.27	3.80	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	412.08	29.13	4.86	9.71	1.82	10.32	4.25	4.86	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	519.68	31.63	18.08	31.63	0.00	9.04	22.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	507.39	33.77	3.29	15.65	0.82	14.00	1.65	6.59	0.00	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	30.36	8.93	1.39	0.99	0.20	1.59	0.40	0.79	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	45.43	4.54	2.60	0.65	0.32	1.95	0.32	0.97	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	45.84	6.11	1.02	3.06	0.00	2.04	0.00	1.02	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	56.48	13.93	2.32	3.09	0.00	3.09	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	55.04	19.14	5.67	3.78	1.89	2.13	0.47	3.54	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	61.86	17.14	6.49	3.94	0.46	3.71	1.85	0.70	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	8.55	17.09	0.00	4.27	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	54.66	14.08	14.80	1.44	6.99	0.62	0.62	0.31	0.31	0.10
mesothelioma cell line:Mero-25	10850-111F4	321.37	20.43	47.89	6.58	14.07	8.17	13.84	1.13	2.04	1.36
mesothelioma cell line:Mero-41	10851-111F5	170.40	7.58	13.94	11.98	4.40	0.73	0.24	0.49	0.73	1.47
mesothelioma cell line:Mero-48a	10852-111F6	98.09	18.82	12.40	7.53	5.76	0.22	0.44	0.00	0.00	1.11
mesothelioma cell line:Mero-82	10853-111F7	261.23	23.65	19.45	7.36	13.67	3.68	4.47	1.31	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	38.13	11.23	8.51	2.55	2.89	0.17	0.51	0.17	0.00	0.51
mesothelioma cell line:Mero-84	10855-111F9	60.92	7.58	12.13	6.32	1.77	0.25	0.76	0.25	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	162.32	21.95	19.25	8.28	4.97	1.24	0.83	1.04	1.04	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	59.96	20.87	9.44	5.30	7.45	0.99	0.83	0.66	0.33	0.66
mesothelioma cell line:NCI-H226	10846-111E9	99.55	14.30	19.55	3.98	12.67	1.81	1.27	1.27	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	69.01	21.35	15.54	4.61	3.25	1.71	0.85	0.51	0.51	0.17
mesothelioma cell line:NCI-H28	10845-111E8	110.18	8.14	13.74	7.13	3.05	1.02	0.25	1.02	1.27	1.27
mesothelioma cell line:No36	10857-111G2	136.03	8.16	39.47	7.50	5.87	0.65	0.65	0.33	2.61	0.33
mesothelioma cell line:ONE58	10858-111G3	148.75	29.80	17.34	7.86	7.59	0.81	1.63	0.27	0.00	1.08
migratory langerhans cells, donor1	11901-125F2	70.05	17.27	1.73	5.37	5.57	1.15	0.38	0.19	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	95.01	18.07	0.49	6.84	3.18	0.85	0.00	0.12	0.00	0.37
migratory langerhans cells, donor3	11903-125F4	84.89	20.64	0.36	6.10	1.97	0.54	0.18	0.36	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	255.63	18.94	11.75	5.22	3.59	8.49	5.22	5.22	0.00	3.92
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	157.04	11.23	53.83	8.48	7.63	0.85	1.91	0.85	3.39	1.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	205.94	28.79	17.28	5.99	5.99	6.91	0.23	2.53	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	25.31	7.61	4.00	1.33	7.04	1.14	0.38	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	125.10	24.58	43.06	5.73	19.96	4.44	0.55	2.77	2.59	0.74
myeloma cell line:PCM6	10474-106I6	330.50	25.50	28.66	5.14	7.91	6.33	1.78	3.36	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	154.22	8.62	9.13	12.17	5.58	0.00	0.00	0.00	1.01	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	103.76	15.30	3.92	6.67	2.35	2.16	0.59	0.59	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	660.53	57.83	32.09	27.08	7.69	9.47	6.46	7.80	0.89	0.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	679.51	61.41	30.59	31.40	8.75	7.80	6.25	5.96	1.40	1.99
nasal epithelial cells, donor2	12227-129F4	274.34	20.42	12.14	7.73	2.21	8.83	5.52	1.66	0.55	2.21
neuroblastoma cell line:CHP-134	10508-107D4	146.55	8.97	34.05	7.59	11.04	4.14	0.92	6.44	0.69	0.23
neuroblastoma cell line:NB-1	10539-107G8	47.71	11.97	28.44	5.61	4.12	0.19	0.00	0.19	1.31	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	217.00	57.57	57.99	4.43	5.48	12.65	6.12	1.48	1.69	0.63
neuroblastoma cell line:NH-12	10555-107I6	147.59	10.25	38.76	6.89	9.69	3.91	2.80	1.49	0.93	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.16	6.88	27.28	1.90	2.14	0.71	0.24	0.47	0.95	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	193.54	23.44	41.02	9.66	0.95	7.13	2.69	3.33	2.38	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	56.96	3.42	75.87	5.84	6.64	1.61	0.81	0.40	6.84	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	99.18	10.81	25.43	13.35	5.72	1.91	0.00	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	87.30	8.78	3.99	5.32	0.00	0.53	0.00	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	74.37	44.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	195.84	46.51	30.44	11.67	6.93	13.36	3.21	5.75	1.52	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	80.05	3.20	44.83	5.60	8.81	0.00	0.80	0.00	1.60	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	144.91	13.79	2.89	6.09	1.60	3.53	1.60	2.24	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	110.89	15.77	2.36	3.94	0.79	1.58	1.31	1.05	0.00	2.36
nucleus accumbens, adult, pool1	10037-101F1	63.18	10.22	8.62	3.47	2.81	0.19	0.00	0.00	0.19	0.00
occipital cortex - adult, donor10196	10172-103C1	32.97	8.24	24.72	0.00	6.18	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	103.32	29.52	9.39	1.61	3.76	0.27	0.27	0.27	0.81	0.27
occipital cortex, newborn, donor10223	10355-105E4	88.44	33.12	10.55	3.64	3.28	2.55	0.73	1.09	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	39.36	5.77	11.55	2.62	5.77	0.00	0.52	0.00	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	39.91	5.15	12.87	3.00	0.00	0.43	0.43	0.00	1.29	0.00
occipital pole, adult, pool1	10036-101E9	61.58	9.15	14.19	3.39	6.23	0.00	0.16	0.32	0.24	0.08
olfactory region, adult	10195-103E6	48.53	15.48	8.41	4.39	2.87	0.19	0.38	0.00	0.00	0.19
optic nerve, donor1	10277-104E7	132.07	14.01	2.00	4.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	1049.66	48.64	133.04	44.77	78.14	4.78	1.71	2.51	1.94	1.48
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	376.03	17.31	130.93	24.73	21.57	2.06	4.53	1.79	4.40	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	401.30	11.18	13.72	16.42	4.40	1.02	2.37	0.51	1.19	2.03
oral squamous cell carcinoma cell line:SAS	10544-107H4	371.36	36.04	61.57	25.64	11.55	3.47	2.08	3.47	1.85	1.50
osteoclastoma cell line:Hs 706.T	10704-109H2	170.50	16.76	1.47	7.94	0.88	2.94	0.88	0.59	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	101.84	14.02	3.74	5.61	4.67	2.80	0.00	3.74	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	96.70	15.69	6.57	4.03	8.69	0.42	0.42	0.42	0.00	0.21
ovary, adult, pool1	10020-101D2	78.44	6.73	1.92	2.53	0.26	1.22	0.52	0.61	0.17	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	23.10	6.42	0.73	1.65	3.30	0.55	0.55	0.37	0.18	0.18
pancreas, adult, donor1	10049-101G4	36.68	2.82	12.23	6.58	0.94	0.94	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	106.22	10.06	39.69	7.55	17.89	4.19	4.75	0.28	1.12	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	283.47	29.98	28.62	6.30	8.18	2.73	3.75	3.41	1.70	2.90
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	164.92	24.34	11.76	5.80	5.30	2.15	0.33	0.17	0.66	0.00
paracentral gyrus, adult, pool1	10035-101E8	57.93	8.24	13.73	2.93	7.50	0.09	0.09	0.18	0.00	0.18
parietal cortex, adult, donor10258	10373-105G4	33.76	11.01	6.61	0.00	1.47	0.00	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	45.14	7.52	9.40	2.82	2.82	0.00	0.00	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	69.26	19.67	10.83	3.42	3.42	0.00	0.00	0.29	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	53.14	9.43	12.95	2.47	5.73	0.00	0.09	0.00	0.18	0.00
parietal lobe, fetal, donor1	10072-101I9	35.88	5.82	13.58	4.85	0.00	0.97	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	103.93	41.87	8.97	6.36	2.99	1.87	1.12	0.00	0.00	0.00
parotid gland, adult	10199-103F1	110.38	9.87	28.37	4.32	1.85	0.00	2.47	0.62	0.62	0.62
penis, adult	10200-103F2	56.93	10.21	1.61	3.76	0.54	0.00	0.00	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	121.23	35.33	21.75	11.90	3.35	2.42	0.74	1.49	0.37	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	344.13	20.69	39.63	16.17	5.83	3.79	1.17	1.46	6.41	1.17
pineal gland - adult, donor10196	10179-103C8	79.34	43.22	0.00	4.52	0.00	0.65	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	56.26	49.15	1.18	1.78	0.00	0.00	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	51.42	58.94	3.14	5.02	0.00	0.63	0.00	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	50.59	23.27	1.01	4.05	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	60.98	18.76	0.00	2.61	1.04	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	21.28	16.17	0.00	2.55	0.00	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	177.59	20.10	6.45	8.71	7.20	0.97	0.75	0.75	0.22	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	65.55	37.34	14.96	3.58	13.77	5.43	1.59	2.78	0.40	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	26.46	12.76	1.71	2.02	0.93	0.62	0.00	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	54.39	5.59	10.84	2.41	9.12	0.26	0.09	0.00	0.26	0.17
postcentral gyrus, adult, pool1	10032-101E5	62.68	9.59	14.30	3.66	9.15	0.17	0.35	0.00	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	244.69	35.55	0.00	20.91	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	0.00	16.52	11.02	0.00	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	84.48	27.97	29.13	6.41	6.26	3.20	1.31	1.17	3.64	0.44
prostate cancer cell line:PC-3	10439-106E7	56.08	16.52	17.06	3.09	3.81	0.54	0.73	0.36	0.73	0.00
prostate, adult, pool1	10022-101D4	52.60	9.43	1.54	2.99	0.09	1.00	0.00	0.18	0.18	0.00
putamen, adult, donor10196	10176-103C5	65.39	14.64	7.79	4.25	0.71	0.24	0.00	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	105.88	23.53	3.92	9.80	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	56.83	12.02	19.67	2.19	7.65	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	48.08	7.25	4.59	3.62	0.72	0.00	0.00	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	114.70	78.71	9.75	0.75	0.75	3.75	5.25	0.00	0.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	271.15	32.29	14.55	8.44	6.40	3.20	6.69	1.16	1.16	0.00
rectum, fetal, donor1	10067-101I4	40.34	12.52	4.17	2.78	0.00	1.39	0.00	2.78	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	72.93	31.16	17.38	6.57	2.97	1.70	1.06	0.42	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	98.17	26.51	8.28	5.38	10.36	1.24	0.41	3.31	0.00	0.00
retina, adult, pool1	10030-101E3	186.47	15.01	1.69	6.56	0.10	0.99	0.40	0.50	0.00	0.20
retinoblastoma cell line:Y79	10475-106I7	25.72	6.24	61.31	2.34	14.81	0.26	0.00	0.26	2.08	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	24.96	6.15	18.44	2.21	4.67	0.49	0.12	0.00	0.49	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	190.94	31.49	33.74	12.65	2.25	3.37	1.41	1.41	1.41	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	53.05	15.91	0.00	2.27	0.00	1.52	0.76	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	73.48	17.80	6.15	3.24	1.94	1.13	0.97	1.13	0.16	0.00
salivary acinar cells, donor2	11772-123I8	52.87	15.97	3.58	2.48	0.83	0.69	0.55	0.41	0.55	0.00
salivary acinar cells, donor3	11773-123I9	66.87	11.25	1.32	5.30	0.00	0.66	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	93.23	8.01	21.16	6.86	0.57	0.00	0.57	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	108.93	38.45	6.66	5.99	3.37	3.88	2.28	3.20	0.17	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	104.03	37.73	5.64	6.70	4.00	4.11	2.70	3.17	0.12	0.82
seminal vesicle, adult	10201-103F3	76.19	11.64	1.06	3.17	0.00	0.53	1.59	0.00	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	224.71	42.75	18.95	11.66	4.13	3.16	4.62	0.24	1.21	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	170.61	9.56	1.26	6.54	0.50	2.01	1.51	2.52	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	119.42	10.04	7.02	6.02	0.00	0.00	0.00	0.00	3.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	420.56	11.42	13.16	26.86	4.70	1.75	3.49	0.67	0.13	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	442.77	44.43	22.00	21.22	8.18	6.30	2.54	2.54	0.77	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	108.90	32.39	47.22	10.71	10.97	0.90	0.65	0.00	0.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	75.90	6.38	0.71	3.55	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	65.01	3.12	1.44	4.20	0.24	1.32	0.12	0.60	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	23.12	3.02	3.02	2.01	0.00	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	6.79	13.57	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	58.70	8.21	8.21	5.05	1.26	0.63	0.00	0.63	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	26.01	11.34	15.68	0.67	0.33	0.67	0.33	0.00	2.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	117.57	30.57	28.68	2.21	4.10	0.95	0.95	0.00	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	27.95	5.01	25.25	4.82	0.58	0.39	0.19	0.19	2.12	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	391.63	65.11	48.79	29.67	22.58	7.25	3.63	4.45	1.98	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	60.32	13.03	35.39	6.92	5.63	0.48	0.32	0.64	0.97	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	339.73	74.53	45.11	20.27	12.64	9.37	2.83	1.31	0.87	1.09
small intestine, adult, pool1	10024-101D6	108.93	19.47	2.15	4.30	0.24	0.12	0.48	0.00	0.48	0.12
small intestine, fetal, donor1	10064-101I1	50.37	16.22	2.70	2.70	0.00	0.49	0.25	0.49	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	291.84	23.59	90.27	16.41	12.31	1.03	2.05	0.00	4.62	2.05
smooth muscle, adult, pool1	10048-101G3	32.05	6.98	0.52	2.33	0.00	0.78	0.00	0.26	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	488.60	27.34	17.69	15.28	4.56	1.88	0.80	0.54	1.88	0.54
spinal cord - adult, donor10196	10181-103D1	58.27	19.27	2.98	2.75	0.23	1.15	0.23	0.46	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	115.13	48.89	2.37	3.55	0.00	1.58	1.18	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	85.78	39.43	1.38	7.61	4.15	2.77	0.69	0.00	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	68.91	24.39	7.93	4.88	3.66	0.00	0.00	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	174.50	45.00	3.21	10.10	1.38	4.59	1.38	0.92	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	128.59	8.36	2.54	5.23	0.30	1.94	0.45	0.30	0.00	0.15
spleen, adult, pool1	10025-101D7	48.35	2.42	5.95	2.20	1.10	0.33	0.00	0.00	0.22	0.11
spleen, fetal, pool1	10044-101F8	73.18	8.42	4.21	2.86	0.56	0.72	0.32	0.32	0.40	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	19.25	11.80	9.21	1.66	3.31	0.10	0.00	0.31	0.21	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	321.65	25.06	51.84	17.09	8.16	3.99	1.52	2.85	4.56	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	128.60	29.70	29.00	4.54	9.44	2.80	0.70	1.05	1.75	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	197.42	115.32	8.60	3.91	5.08	10.16	2.74	7.04	0.78	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	339.25	157.47	36.36	10.47	11.48	21.16	3.94	7.09	1.80	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	260.52	14.83	108.02	16.94	14.40	1.27	1.69	0.42	3.81	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	74.04	38.50	22.42	4.23	6.35	2.96	0.42	1.69	0.00	0.00
stomach, fetal, donor1	10062-101H8	34.18	9.61	5.34	0.00	0.00	0.00	0.00	0.00	2.14	0.00
submaxillary gland, adult	10202-103F4	59.82	3.99	7.98	1.14	1.14	0.57	1.71	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	113.62	30.12	4.57	2.91	0.21	0.00	0.21	0.00	0.00	0.83
substantia nigra, adult, donor10258	10371-105G2	78.10	19.66	10.86	4.66	5.69	0.52	0.00	0.00	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	112.35	60.06	4.24	2.83	1.41	0.71	2.12	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	36.45	6.19	21.55	3.44	2.52	0.00	0.23	0.23	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	77.90	8.22	13.90	4.58	6.02	0.34	0.17	0.17	0.17	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	58.41	6.41	14.96	9.26	0.00	0.71	0.00	0.00	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	65.05	7.47	20.22	5.71	2.64	0.44	0.00	0.44	0.44	0.00
tenocyte, donor1	11763-123H8	24.79	10.47	1.05	2.79	1.05	0.35	0.00	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	87.75	8.77	2.29	6.87	1.14	1.91	0.76	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	34.84	7.41	1.11	1.11	0.37	0.00	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	51.50	17.00	69.34	2.55	20.91	2.04	2.21	0.34	4.25	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	20.19	3.85	10.79	2.00	2.00	0.00	0.15	0.00	1.39	0.15
teratocarcinoma cell line:PA-1	10807-111A6	62.15	18.44	34.25	4.80	3.56	1.08	1.39	0.31	2.63	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	138.88	15.23	69.95	6.09	31.10	1.78	3.81	0.89	3.43	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	150.89	29.88	57.86	5.29	22.31	2.65	4.16	0.00	3.40	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	255.21	26.17	34.57	9.49	13.31	4.14	14.83	1.74	0.98	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	71.65	6.51	38.43	5.21	8.79	0.98	0.98	0.98	4.89	0.65
testis, adult, pool1	10026-101D8	88.58	4.62	1.61	6.76	0.11	0.32	0.21	0.11	0.11	0.21
testis, adult, pool2	10096-102C6	147.50	9.02	6.77	10.83	0.00	0.45	0.45	0.45	0.45	1.35
thalamus - adult, donor10196	10168-103B6	78.38	18.77	1.10	2.21	1.10	2.21	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	99.55	24.54	4.38	2.19	0.00	0.00	0.31	0.00	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	150.88	32.33	4.62	7.70	9.24	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	38.37	17.62	7.74	1.98	5.93	0.33	0.16	0.00	0.33	0.16
thalamus, newborn, donor10223	10366-105F6	111.61	51.20	4.03	2.30	5.18	4.03	4.03	3.45	0.00	0.58
throat, adult	10209-103G2	52.68	6.49	6.99	2.75	0.50	0.50	0.75	0.00	0.00	0.25
throat, fetal, donor1	10061-101H7	37.78	10.36	2.13	3.96	0.30	1.22	0.30	0.30	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	10.53	8.94	78.30	1.59	8.15	0.60	0.00	0.00	1.79	0.00
thymus, adult, pool1	10027-101D9	32.91	1.39	7.95	3.68	1.19	0.00	0.20	0.10	0.20	0.00
thymus, fetal, pool1	10043-101F7	64.42	9.97	7.79	5.09	0.42	1.04	0.83	0.94	0.52	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	124.32	26.46	1.99	6.91	3.99	5.85	3.06	2.79	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	166.09	28.22	23.47	8.24	3.63	4.33	1.26	3.07	2.51	0.70
thyroid, adult, pool1	10028-101E1	99.10	11.29	0.75	8.77	0.00	1.21	0.19	0.75	0.19	0.00
thyroid, fetal, donor1	10060-101H6	35.86	21.09	0.53	3.95	0.00	0.79	0.00	0.26	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	175.54	30.80	6.16	9.24	0.00	0.00	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	63.73	9.30	10.47	4.88	2.79	0.00	0.93	0.00	0.47	0.70
tongue, fetal, donor1	10059-101H5	30.74	0.79	2.36	3.15	0.00	0.79	0.00	0.00	0.79	0.00
tonsil, adult, pool1	10047-101G2	58.70	9.62	12.12	3.41	2.20	0.10	0.00	0.00	0.70	0.00
trachea, adult, pool1	10029-101E2	58.24	8.75	3.44	4.01	0.65	0.16	0.00	0.33	0.16	0.08
trachea, fetal, donor1	10058-101H4	46.55	13.46	1.92	1.15	0.00	0.38	0.00	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	69.08	10.63	0.35	3.19	0.71	1.06	0.00	1.06	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	241.03	16.62	19.15	14.69	6.28	2.74	2.13	2.23	0.30	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	155.43	42.31	28.83	11.75	11.44	7.36	3.92	6.89	1.25	0.78
tridermal teratoma cell line:HGRT	10694-109G1	64.69	9.51	1.90	3.81	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	150.34	13.46	9.31	8.13	1.44	2.45	0.93	0.51	0.76	0.00
umbilical cord, fetal, donor1	10057-101H3	27.12	12.52	2.09	2.09	0.00	0.00	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	70.64	14.84	1.54	5.97	0.17	3.24	0.34	1.19	0.00	0.00
uterus, fetal, donor1	10055-101H1	32.76	15.87	2.05	2.56	1.02	2.05	1.54	0.00	0.00	0.51
vagina, adult	10204-103F6	141.52	10.34	0.65	2.58	0.00	3.23	0.65	0.00	0.65	0.65
vein, adult	10191-103E2	43.62	4.60	1.53	1.53	0.44	0.00	0.44	0.00	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	32.04	15.22	4.27	2.40	2.94	1.87	0.27	1.07	0.27	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000681215.1:-20 ENST00000377889.6:-37 BC003000:-37 ENST00000377891.6:-70 ENST00000680725.1:-70 AK025584:-70 ENST00000538084.2:-72 ENST00000681569.1:-72 NM_001012664.3:-72 NM_001012662.3:-72 NM_002394.6:-72 ENST00000377890.6:-79 ENST00000681467.1:-79 BC001061:-79 ENST00000680729.1:-177 ENST00000680002.1:-177" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.